JPH0243728B2 - - Google Patents
Info
- Publication number
- JPH0243728B2 JPH0243728B2 JP56099783A JP9978381A JPH0243728B2 JP H0243728 B2 JPH0243728 B2 JP H0243728B2 JP 56099783 A JP56099783 A JP 56099783A JP 9978381 A JP9978381 A JP 9978381A JP H0243728 B2 JPH0243728 B2 JP H0243728B2
- Authority
- JP
- Japan
- Prior art keywords
- bis
- ch2ch2nh
- amino
- hydroxyethylamino
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 claims description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 33
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 31
- 239000000203 mixture Substances 0.000 claims description 29
- 150000004056 anthraquinones Chemical class 0.000 claims description 21
- -1 ethyleneimino-ethyleneimino Chemical group 0.000 claims description 21
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 20
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 claims description 19
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 10
- 230000003647 oxidation Effects 0.000 claims description 9
- 238000007254 oxidation reaction Methods 0.000 claims description 9
- UGNWTBMOAKPKBL-UHFFFAOYSA-N tetrachloro-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(Cl)=C(Cl)C1=O UGNWTBMOAKPKBL-UHFFFAOYSA-N 0.000 claims description 5
- BKNBVEKCHVXGPH-UHFFFAOYSA-N anthracene-1,4,9,10-tetrol Chemical compound C1=CC=C2C(O)=C3C(O)=CC=C(O)C3=C(O)C2=C1 BKNBVEKCHVXGPH-UHFFFAOYSA-N 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims description 3
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims description 3
- 125000005263 alkylenediamine group Chemical group 0.000 claims description 2
- 239000012298 atmosphere Substances 0.000 claims description 2
- 239000012442 inert solvent Substances 0.000 claims 2
- 239000007787 solid Substances 0.000 description 31
- 239000000047 product Substances 0.000 description 19
- 206010028980 Neoplasm Diseases 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 239000000243 solution Substances 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 239000002585 base Substances 0.000 description 9
- FAGUFWYHJQFNRV-UHFFFAOYSA-N tetraethylenepentamine Chemical compound NCCNCCNCCNCCN FAGUFWYHJQFNRV-UHFFFAOYSA-N 0.000 description 9
- 239000004480 active ingredient Substances 0.000 description 8
- 201000011510 cancer Diseases 0.000 description 8
- 238000009835 boiling Methods 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 239000012299 nitrogen atmosphere Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 102000053602 DNA Human genes 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 239000003937 drug carrier Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 208000032839 leukemia Diseases 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 3
- QJQPINQAQJTYMH-UHFFFAOYSA-N 5,8,9,10-tetrahydroxy-2,3-dihydroanthracene-1,4-dione Chemical compound O=C1CCC(=O)C2=C1C(O)=C1C(O)=CC=C(O)C1=C2O QJQPINQAQJTYMH-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 239000002612 dispersion medium Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 238000009830 intercalation Methods 0.000 description 3
- QTWZICCBKBYHDM-UHFFFAOYSA-N leucomethylene blue Chemical compound C1=C(N(C)C)C=C2SC3=CC(N(C)C)=CC=C3NC2=C1 QTWZICCBKBYHDM-UHFFFAOYSA-N 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 150000007530 organic bases Chemical class 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229960002949 fluorouracil Drugs 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000004474 heteroalkylene group Chemical group 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 230000002687 intercalation Effects 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 239000007951 isotonicity adjuster Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 208000003747 lymphoid leukemia Diseases 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- STROKFBTTJPGBP-UHFFFAOYSA-N 1,2,3,4-tetrahydroxyanthracene-9,10-dione Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=C(O)C(O)=C3C(=O)C2=C1 STROKFBTTJPGBP-UHFFFAOYSA-N 0.000 description 1
- VOEMLSBPODOHJQ-UHFFFAOYSA-N 1,4-bis(2-aminoethylamino)-5,8-dihydroxyanthracene-9,10-dione;hydron;dichloride Chemical compound Cl.Cl.O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCN)=CC=C2NCCN VOEMLSBPODOHJQ-UHFFFAOYSA-N 0.000 description 1
- PWGJDPKCLMLPJW-UHFFFAOYSA-N 1,8-diaminooctane Chemical compound NCCCCCCCCN PWGJDPKCLMLPJW-UHFFFAOYSA-N 0.000 description 1
- WXIRBHKGDIUZAA-UHFFFAOYSA-N 1-aminoanthracene-9,10-dione dihydrochloride Chemical compound Cl.Cl.Nc1cccc2C(=O)c3ccccc3C(=O)c12 WXIRBHKGDIUZAA-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 238000011765 DBA/2 mouse Methods 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000002250 Hematologic Neoplasms Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000003070 absorption delaying agent Substances 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- LHIJANUOQQMGNT-UHFFFAOYSA-N aminoethylethanolamine Chemical compound NCCNCCO LHIJANUOQQMGNT-UHFFFAOYSA-N 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000003855 balanced salt solution Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- WJTCGQSWYFHTAC-UHFFFAOYSA-N cyclooctane Chemical group C1CCCCCCC1 WJTCGQSWYFHTAC-UHFFFAOYSA-N 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000010687 lubricating oil Substances 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 229960001156 mitoxantrone Drugs 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- RNOXZIRABZEMHY-UHFFFAOYSA-N n,n'-bis(2-aminoethyl)but-2-ene-1,4-diamine Chemical compound NCCNCC=CCNCCN RNOXZIRABZEMHY-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000010525 oxidative degradation reaction Methods 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- SCHTXWZFMCQMBH-UHFFFAOYSA-N pentane-1,3,5-triamine Chemical compound NCCC(N)CCN SCHTXWZFMCQMBH-UHFFFAOYSA-N 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960001922 sodium perborate Drugs 0.000 description 1
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- 229910001428 transition metal ion Inorganic materials 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F5/00—Softening water; Preventing scale; Adding scale preventatives or scale removers to water, e.g. adding sequestering agents
- C02F5/08—Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents
- C02F5/10—Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents using organic substances
- C02F5/12—Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents using organic substances containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doublyâbound oxygen atoms bound to the same carbon skeleton, at least one of the doublyâbound oxygen atoms not being part of a âCHO group, e.g. amino ketones
- C07C225/24—Compounds containing amino groups and doublyâbound oxygen atoms bound to the same carbon skeleton, at least one of the doublyâbound oxygen atoms not being part of a âCHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doublyâbound oxygen atoms bound to the same carbon skeleton, at least one of the doublyâbound oxygen atoms not being part of a âCHO group, e.g. amino ketones
- C07C225/24—Compounds containing amino groups and doublyâbound oxygen atoms bound to the same carbon skeleton, at least one of the doublyâbound oxygen atoms not being part of a âCHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings
- C07C225/26—Compounds containing amino groups and doublyâbound oxygen atoms bound to the same carbon skeleton, at least one of the doublyâbound oxygen atoms not being part of a âCHO group, e.g. amino ketones the carbon skeleton containing carbon atoms of quinone rings having amino groups bound to carbon atoms of quinone rings or of condensed ring systems containing quinone rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hydrology & Water Resources (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯ãæ°èŠãªææ©ååç©ã«é¢ããããã«è©³
ããã¯ãäžè¬åŒ åŒäžã âã¯ãâCH2âCH2âãŸãã¯âCHïŒCHâ
ã§ããïŒ ïŒ±ã¯ãâCH2CH2NHâCH2CH2OHãâ
CH2CH2NHâCH2CH2NH2ãŸãã¯â
CH2CH2NHâCH2CH2NHCH3ã§ããïŒãã
㊠ã¯ãâïŒCH2ïŒïœâãããã§ïœã¯ïŒãïŒã®æŽæ°
ã§ãããâCH2CH2NHâCH2CHïŒCHCH2NH
âCH2CH2âã âïŒCH2ïŒ3NHâïŒCH2ïŒ4NHâïŒCH2ïŒ3âãâ
CH2CH2âïŒNHCH2CH2ïŒïœâãããã«ïœã¯
ïŒãïŒã®æŽæ°ã§ããããŸãã¯âCH2CH2NHâ
ïŒCH2ïŒïœâNHCH2CH2âãããã« ïœã¯ïŒãïŒã®æŽæ°ã§ããã ã§è¡šããããšãã§ããæ°èŠãªãããã¢ã«ãã¬ã³ã
ã¹ã¢ã³ã¹ã©ããã³é¡ïŒããã³è£œè¬åŠçã«èš±å®¹ãã
ããããã®é žåå å¡©ã«é¢ããã ãŸããæ¬çºæã®ç¯å²å ã«ã¯ã次ã®äžè¬åŒã§è¡šã
ãããšãã§ãããã€ã³å¡©åºããã³äºå€ç°æ§äœãå
å«ãããïŒ åŒäžïŒ±ããã³ïŒ¡ã¯äžã«å®çŸ©ãããšããã§ããã æè¿ãK.C.MurdockïŒet alïŒïŒJ.Med.Chem.ïŒ
22ïŒ1024ïŒ1979ïŒã¯ãæž©è¡åç©ã«ãããŠæç掻æ§
ã瀺ãäžçŸ€ã®ïŒïŒïŒâãã¹ãïŒã¢ããã¢ã«ãã«ïŒ
ã¢ãããã¢ã³ã¹ã©ããã³é¡ãåæããããããã®
ååç©ã®ããã€ããããã«ç 究ããããããã¯ã
ãªãã·ãªãæ žé žïŒDNAïŒã®æ žé žããŒã¹ã®é£ç¶ã
ã察ã®éã«ã¯ããŸããããšã«ãããDNAã«çµå
ããããšã瀺ããããJohnsonïŒet alïŒïŒ
Cancer Treatment ReportsïŒ63ïŒ425ïŒ1979ïŒãã
ãã®åã®DNAãžã®ããçš®ã®å¹³ããªå€ç°åŒè³éŠæ
ååã®ããå ¥çµåã¯å ¥ããã¿ïŒintercalationïŒãš
åŒã°ãããŸãããçš®ã®ä»ã®è¬ç©ã®ç¹è²ã§ããã
ãSchwartzïŒBiomedicineïŒ24ïŒ317ïŒ1976ïŒãã äžã®J.MedïŒChem.ã®æç®ã«èšèŒãããŠããå
åç©ãªãã³ã«æ¬çºæã®ååç©ã®äœçšã®æ©æ§ã¯ç«èšŒ
ãããŠããªãããçºæè ãã®äºæž¬ã«ãããšãé©åœ
ãªå¡©åºæ§åŽéãæããã¢ã³ã¹ã©ããã³æ žã¯ç现è
ã®DNAäžã«å ¥ãããããšãã§ããããããç现
èã®å¢æ®ãé»æ¢ããããã«é©åœãªçµååäœã«ãã€
ãŠçµåããããïŒã€ã®ãã®ãããªã¢ã³ã¹ã©ããã³
ç³»ã¯åãDNAéã®ïŒã€ã®äœçœ®ã®äžã«å ¥ãããã
ãšãã§ããããã«ãã€ãŠãã倧ãã匷ãããã³èœ
åããã€ãŠçµåããããšãã§ããããããã¯ãã
ã®ãããªäºéã®çµåããªãã¡ãã¹âã€ã³ã¿ãŒã«ã¬
ãŒã·ãšã³ïŒbisâintercalationïŒã¯åžžæ ã§äºéã®
ã¹ãã©ã³ãåããDNAã®é£æ¥ã¹ãã©ã³ããçµå
ããããã«ãã€ãŠãDNAã®è€è£œããã³çŽ°èã®å¢
æ®ã«å¿ èŠã§ããããšãç¥ãããŠãããã¹ãã©ã³ã
ã®åé¢ãé²ãããšãã§ããããŸãããã®ãããªäº
éåããã¢ã³ã¹ã©ããã³ã®äžç«¯ãŸãã¯äž¡ç«¯ãä»ã®
现èæåãããšãã°ã现èèãããã³ã³ããªã¢ã
ãªã³èèªè³ªãŸãã¯ããã±ã質ãžçµåããå Žåãå¢
æ®ã¯åæ§ã«åŠšå®³ãããã äœçšã®çååŠçæ©æ§ã¯ç¢ºç«ãããŠããªããã以
äžã«è©³è¿°ããçºæã¯çãæããããŠã¹ã®å¯¿åœãå®
質çã«å»¶é·ããäžç³»åã®ãã¹ã¢ã³ã¹ã©ããã³é¡ã
èšèŒããã æ¬çºæã®æ°èŠãªååç©ã¯ãç¹åŸŽããèç¹ãšåžå
ã¹ãã¯ãã«ãæããèµ€å³ãã€è²ãªããéé»è²åºäœ
ãšããŠåŸãããšãã§ãããããŠéé¢å¡©åºã®å€ãã¯
æ°ŽäžæŽ»æ§ã§ããããããŠãããã®ãããã®ã¯å€§ãŠ
ãã®ææ©æº¶åªã«äžæŽ»æ§ã§ããã®ã§ãäœçŽã¢ã«ã«ã
ãŒã«ã§æµžåºããããšã«ãã粟補ã§ãããæ¬çºæã®
ææ©å¡©åºïŒãããã³ïŒã¯ãçš®ã ã®è¬çåŠç
ã«èš±å®¹ãããææ©ããã³ç¡æ©ã®å¡©åœ¢æè©Šè¬ãšé žå
å å¡©ã圢æãããããããŠãææ©å¡©åºãšé žãšãã
é©åœã«ã¯äžæ§æº¶åªäžã§ãæ··åããããšã«ãã圢æ
ãããé žåå å¡©ã¯ãç¡«é žããªã³é žãå¡©åæ°ŽçŽ é žã
èåæ°ŽçŽ é žãã¹ã«ãã¢ãã³é žãã¯ãšã³é žãä¹³é žã
ãªã³ãŽé žãã³ãã¯é žãé ç³é žãé ¢é žãã°ã«ã³ã³
é žãã¢ã¹ã³ã«ãã³é žãªã©ã®ãããªé žã§åœ¢æãã
ããæ¬çºæã®ç®çã«å¯ŸããŠãéé¢å¡©åºã¯ãããã®
é žä»å å¡©ãšåçã§ãããæ¬çºæã®ææ©å¡©åºã®é žä»
å å¡©ã¯åºäœã§ããããããã®ã»ãšãã©ã¯æ°Žã«æ¯èŒ
ç溶ãããããã¹ãŠã¯é極æ§ææ©æº¶åªãããšãã°
ãžãšãã«ãšãŒãã«ããã³ãŒã³ããã«ãšã³ãªã©ã«æ¯
èŒçäžæº¶æ§ã§ããã æ¬çºæã®æ°èŠãªååç©ã¯ã次ã®åå¿ã«åŸã容æ
ã«è£œé ã§ããïŒ åŒäžïŒ¡ããã³ïŒ±ã¯äžã«å®çŸ©ãããšããã§ããã
ãã®åå¿ã«åŸããšããã€ã³ïŒïŒïŒïŒïŒïŒïŒâãã
ã©ããããã·ã¢ã³ã¹ã©ããã³ãŸãã¯ãã€ã³ããã¶
ãªã³ïŒïŒãé©åœãªãããã¢ã«ãã¬ã³ãžã¢ãã³
ïŒïŒãšçªçŽ ãµãå²æ°ã®ããšã«ïŒâã¡ããã·ãšã¿
ããŒã«ããšã¿ããŒã«ããžã¡ãã«ãã«ã ã¢ãããªã©
ã®ãããªæº¶åªäžã§ïŒâã50âã«ãããŠïŒã15æé
ãããŸããŠãåå¿ããïŒïŒ1â²âãã¹ãã€ã³äžéå
åç©ïŒïŒãçæãããïŒâã¡ããã·ãšã¿ããŒã«
äžã®äžéäœïŒïŒãé©åœãªã¢ã«ãã¬ã³ãžã¢ãã³
ïŒïŒãšçŽ40âãçŽ60âã«ãããŠçªçŽ ã®ãµãå²æ°
ã®ããšã«æ°æéçž®åããŠã察å¿ãããã€ã³å¡©åº
ïŒïŒãçæãããäžéäœïŒïŒãŸãã¯ãã€ã³å¡©
åºïŒïŒã®ããããåé¢ããå¿ èŠã¯ãªãããã€ã³
å¡©åºïŒïŒã®å®å šã«è³éŠæã®èªå°äœïŒïŒãžã®é ž
åã¯ãçš®ã ã®æ¹æ³ãããšãã°ã空æ°é žåãç±ãã
ããã³ãŒã³ã«ããåŠçãé žäžã®ã¯ãã©ãã«ã«ãã
åŠçããããã¯éé žåæ°ŽçŽ ãŸãã¯éããŠçŽ é žãã
ãªãŠã ã«ããåŠçã«ããã容æã«å®æœã§ãããé
é žæ§ã®é žåç³»ãçšããå Žåãå·åŽããæ··åç©ã次
ã«é žæ§åãããéãããšãé žåçæç©ã®å¡©ãåŸ
ãããããã®å¡©ã®ç²Ÿè£œã¯ããããæ°Žäžã«æº¶è§£ãã
äžæŽ»æ§æ±æç©è³ªãé å¿åé¢ãã次ãã§é žæ§åºŠã
0.2ãªãã0.8Nã®ç¯å²ã®é žäŸ¡ã«äžããŠåæ²æ®¿ãã
ããšã«ãã€ãŠãå®æœã§ããã粟補ã¯èå±€ã¯ããã
ã°ã©ãã€ãŒã«ããç£èŠãããïŒå¡©ã¯å¡©å¿ã«ããæ²
éãããã€åžé žã§æŽæµãã次ãã§ã¢ã«ã³ãŒã«ãã
ã³ïŒãŸãã¯ã¢ã»ãã³ã§æŽæµããã ããã«èšèŒããæ°èŠãªååç©ã¯ããã¬ãŒãå
å€ãé¯åå€ãŸãã¯éå±ã€ãªã³å°éå€ãšããŠæçšã§
ãããå€äŸ¡éå±ãšåœ¢æããé¯å¡©ã¯ãšãã«å®å®ã§ã
ãããããã®æ§è³ªã«ããããããã®ååç©ã¯ãé
å±ã€ãªã³ãåé¡ãèµ·ããçš®ã ã®ç®çã«æçšã§ã
ããããšãã°ã飜åããã³äžé£œåã®æœ€æ»æ²¹ããã³
çåæ°ŽçŽ ãèèªé žããã³ã¯ãã¯ã¹ã®ãããªçš®ã ã®
ææ©ç³»äžã®å®å®å€ãšããŠãé·ç§»éå±ã€ãªã³ã®æ±æ
ãé žåçå£åããã³çè²ãä¿é²ããå Žåã«ãã
ãŠããã¡ãããæçšã§ããããããã¯ããããã®
ç©è³ªã«ããé¯åãŸãã¯æœåºããããå€äŸ¡éå±ã®å
æã«ãããŠããŸãéå±æ äœãšããŠãããã«æçšã§
ãããéå±ã€ãªã³å°éå€ã«æ®éã®ä»ã®çšéã¯ãã
ããã®ååç©ã«ãšã€ãŠèªæã§ãããããã«ããã€
ã³å¡©åºïŒïŒã¯ãå®å šã«è³éŠæã®èªå°äœïŒïŒã®
補é ã«ãããäžéäœãšããŠæçšã§ããã ãŸããæ¬çºæã®æ°èŠãªååç©ã¯ã次ã®è©Šéšã«ã
ã確ç«ãããããã«ã移æ€ãããããŠã¹ã®è «çã®
æé·ãæå¶ããæ§è³ªãæããã ãªã³ãæ§çœè¡ç P388è©Šéš äœ¿çšããåç©ã¯ããã¹ãŠïŒã€ã®æ§ã®ãäœéãæ
å°17ïœã§ããããã¹ãŠïŒïœã®äœéç¯å²å ã®
DBAïŒïŒããŠã¹ã§ãããåè©Šéšã°ã«ãŒãã¯ïŒå¹
ãŸãã¯ïŒå¹ã®åç©ã§ãããè «çã®ç§»æ€ã¯ã106å
ã®ãªã³ãæ§çœè¡ç P388ã®çŽ°èãå«æããåžè ¹æ°Ž
æµäœã®0.5mlã®è ¹è å 泚å°ã«ãããè©Šéšååç©ã¯ã
第ïŒæ¥ç®ã第ïŒæ¥ç®ããã³ç¬¬ïŒæ¥ç®ïŒè «çã®æ¥çš®
ã«é¢ããŠïŒçš®ã ã®æäžéã§è ¹è å ã«æäžãããèŠ
åæ£ããåºæºã«åºã¥ããŠ30æ¥éãåç©ã秀éãã
çåæ°ãèšé²ãããå¹³åã®çåæéããã³åŠçœ®ã
ãåç©ïŒïŒŽïŒïŒå¯Ÿç §åç©ïŒïŒ£ïŒã®çåæéã®æ¯ã
èšç®ãããéœæ§ã®å¯Ÿç §ååç©ã¯60mgïŒKg泚å°ãšã
ãŠèšèŒããïŒâãã«ãªããŠã©ã·ã«ã§ãããæ¬çºæ
ã®ä»£è¡šçååç©ãçšãããã®è©Šéšã®çµæããè¡š
ã«èšèŒãããå¹åã®å€å®èŠæºã¯ïŒŽïŒïŒ£Ã100125
ïŒ ã§ããã ãè¡šã ãè¡šã ãè¡šã ãè¡šã é»è²è «B16 䜿çšããåç©ã¯ããã¹ãŠåäžæ§ã§ãããæå°äœ
éã17ïœã§ãããã€ãã¹ãŠãïŒïœã®äœéç¯å²å ã§
ããC57BCïŒïŒããŠã¹ã§ãããåè©Šéšã°ã«ãŒã
ã¯10å¹ã®åç©ã§ãããé»è²è «B16ã®ïŒïœã®éšåã
10mlã®å·ãããã©ã³ã¹ãã塩溶液äžã«å質混å
ãããããŠå質åç©ã®0.5mlã®ã¢ãªã³ãŒããè©Šéš
ããŠã¹ã®åã ã®è ¹è å ã«ç§»æ€ãããè©Šéšååç©
ã¯ã第ïŒæ¥ç®ãã第ïŒæ¥ç®ïŒè «çã®æ¥çš®ã«é¢ã
ãŠïŒçš®ã ã®æäžéã§è ¹è å ã«æäžãããèŠåæ£ã
ãåºæºã«åºã¥ããŠ60æ¥éãåç©ã秀éããçåæ°
ãèšé²ãããå¹³åã®çåæéããã³åŠçœ®ããåç©
ïŒïŒŽïŒïŒå¯Ÿç §åç©ïŒïŒ£ïŒã®çåæéã®æ¯ãèšç®ã
ããéœæ§ã®å¯Ÿç §ååç©ã¯20mgïŒKg泚å°ãšããŠèšèŒ
ããïŒâãã«ãªããŠã©ã·ã«ã§ãããæ¬çºæã®ä»£è¡š
çååç©ãçšãããã®è©Šéšã®çµæããè¡šã«èšèŒ
ãããå¹åã®å€å®èŠæºã¯ïŒŽïŒïŒ£Ã100125ïŒ ã§ã
ãã ãè¡šã ãè¡šã ãè¡šã ããã«ãæ¬çºæã®ç¯å²ã«ã¯ã次ã®æ§é åŒ åŒäžã âã¯ãâCH2âCH2âãŸãã¯âCHïŒCHâ
ã§ããïŒ ïŒ±ã¯ãâCH2CH2NHâCH2CH2OHãâ
CH2CH2NHâCH2CH2NH2ãŸãã¯â
CH2CH2NHâCH2CH2NHCH3ã§ããïŒãã
㊠ã¯ãâïŒCH2ïŒïœâãããã§ïœã¯ïŒãïŒã®æŽæ°
ã§ãããâCH2CH2NHâCH2CHïŒCHCH2NH
âCH2CH2âã âïŒCH2ïŒ3NHâïŒCH2ïŒ4NHâïŒCH2ïŒ3âãâ
CH2CH2âïŒNHCH2CH2ïŒïœâãããã«ïœã¯
ïŒãïŒã®æŽæ°ã§ããããŸãã¯âCH2CH2NHâ
ïŒCH2ïŒïœâNHCH2CH2âãããã« ïœã¯ïŒãïŒã®æŽæ°ã§ããïŒ ã§è¡šããããšãã§ãããããçš®ã®ãããã¢ã«ãã¬
ã³ãã¹ã¢ã³ã¹ã©ããã³é¡ïŒãŸãã¯ãããã®ãã€ã³
å¡©åºããã³é žä»å å¡©ïŒãå«æãããåºä¹³åç©ã«ã
ããçã®ç æ°ãæ¹åããã®ã«æçšãªæ²»ççµæç©ã
å å«ããããæ¬çºæã®ãã®é¢ã¯ãåºä¹³åç©ã«ãã
ãçœè¡ç ããã³é¢é£ããè «çã®åŸéããã³ïŒãŸã
ã¯ç·©åãèªçºããæ°èŠãªçµæç©ããã³æ¹æ³ãå å«
ããã æ¬çºæã®æ²»ççµæç©ã®æŽ»æ§æåããã³æ°èŠãªå
åç©ã¯ãçŽïŒmgãçŽ200mgïŒKgäœéïŒæ¥ã®ç¯å²ã®
éã§æäžãããšãã移æ€ããããŠã¹ã®è «çã®æé·
ãæå¶ãããããŠåºä¹³åç©ã«ãããçœè¡ç ããã³
é¢é£ããçã®åŸéããã³ïŒãŸãã¯ç·©åãèªçºã
ããæé©ãªçµæã®å¥œãŸããæäžé€çæ³ã¯çŽïŒmgã
çŽ50mgïŒKgäœéïŒæ¥ã§ããããããŠåèšçŽ350mg
ãçŽ3.5ïœã®æŽ»æ§ååç©ãäœéçŽ70Kgã®æ£è ã«24
æéã§æäžããããããªæäžåäœãçšããããã®
æäžé€çæ³ã¯ãæé©ãªæ²»çåŠçå¿çãåŸãããã
ãã«èª¿æŽã§ãããããšãã°ãããã€ãã«åå²ãã
éãæäžããããšãã§ããïŒæ¥ã®æäžéã¯ãæ²»ç
åŠçå Žåã®å±æ¥ã«ããå¿ èŠãšãããããã«ãæ¯äŸ
çã«æžå°ããããšãã§ããã決å®çãªå®éã®å©ç
ã¯ã掻æ§ååç©ãéèå ãçèå ãŸãã¯ç®äžã®é
çã®ãããªäŸ¿å©ãªæ¹æ³ã§æäžã§ãããšããããšã§
ããã 掻æ§ååç©ã¯ãŸãéçµå£çã«ãŸãã¯è ¹è å ã«æ
äžã§ãããéé¢å¡©åºãŸãã¯è¬çåŠçã«èš±å®¹ããã
å¡©ã®åœ¢ã®æŽ»æ§ååç©ã®æº¶æ¶²ããé©åœã«è¡šé¢æŽ»æ§
å€ãããšãã°ãããããã·ãããã«ã»ã«ããŒã¹ãš
æ··åããæ°ŽãçšããŠèª¿è£œã§ãããåæ£æ¶²ãã°ãªã»
ãªã³ã液ç¶ããªãšãã¬ã³ã°ãªã³ãŒã«ããã³ããã
ãšæ²¹ã®æ··åç©ãçšããŠèª¿è£œã§ãããéåžžã®è²¯èµã
ãã³äœ¿çšæ¡ä»¶äžã§ããããã®èª¿è£œç©ã¯åŸ®çç©ã®ç
è²ãé²æ¢ããããã«é²è å€ãå«æããã 泚å°å¯èœãªäœ¿çšã«é©åœãªè£œè¬åŠç圢æ ã¯ãæ» è
泚å°å¯èœãªæº¶æ¶²ãŸãã¯åæ£æ¶²ãåŠæ¹ç®ã«å¿ããŠèª¿
補ããããã®ãæ» èãã氎溶液ãŸãã¯åæ£æ¶²ãã
ã³æ» èããç²æ«ãå å«ããããã¹ãŠã®å Žåã«ãã
ãŠãåèšåœ¢æ ã¯æ» èããªããŠã¯ãªããããããŠæ³š
å°å®¹æã§ãããããªçšåºŠã«æµåæ§ã§ãªããŠã¯ãªã
ãªããããã¯è£œé ããã³è²¯èµã®æ¡ä»¶äžã§å®å®ã§ãª
ããŠã¯ãªããããããŠåŸ®çç©ããšãã°çŽ°èããã³
çèã®æ±æäœçšã«å¯ŸããŠä¿åãããªããŠã¯ãªããª
ããæ äœã¯ãããšãã°ãæ°Žããšã¿ããŒã«ãããªãª
ãŒã«ïŒããšãã°ãã°ãªã»ããŒã«ããããã¬ã³ã°ãª
ã³ãŒã«ãããã³æ¶²ç¶ããªãšãã¬ã³ã°ãªã³ãŒã«ãª
ã©ïŒãé©åœãªãããã®æ··åç©ãããã³æ€ç©æ²¹ãå«
æãã溶åªãŸãåæ£æ¶²ã®åªè³ªã§ããããšãã§ã
ããé©åãªæµåæ§ã¯ãããšãã°ãã¬ã·ãã³ã®ãã
ãªè¢«èã®äœ¿çšã«ãããåæ£æ¶²ã®å Žåã«ãããŠèŠæ±
ãããç²åºŠãç¶æããããšã«ããããããŠçé¢æŽ»
æ§å€ã®äœ¿çšã«ãããç¶æããããšãã§ããã埮ç
ç©ã®äœçšã¯ãçš®ã ã®æ现èå€ããã³æçèå€ãã
ãšãã°ããã©ãã³ãã¯ãããã¿ããŒã«ãããšããŒ
ã«ããœã«ãã³é žããã¡ããµã«ãªã©ã«ããé²ãããš
ãã§ãããå€ãã®å Žåã«ãããŠãç匵å€ãããšã
ã°ãç ç³ãŸãã¯å¡©åãããªãŠã ãå ããããšã奜
ãŸããã泚å°çµæç©ã®åžåã¯ãåžåãé ãããç©
質ãããšãã°ãã¢ãã¹ãã¢ãªã³é žã¢ã«ãããŠã ã
ãã³ãŒã©ãã³ãçµæç©ã«å«æãããããšã«ããã
延é·ããããšãã§ããã æ» èãã泚å°æº¶æ¶²ã¯ã掻æ§ååç©ãèŠæ±éã§é©
åœãªæº¶åªäžã«ãå¿ èŠã«å¿ããŠãåè¿°ã®ä»ã®æåãš
äžç·ã«ãå質混åãã次ãã§éã«ããæžèãã
ããšã«ãã€ãŠã調補ããããäžè¬ã«åæ£æ¶²ã¯ãåº
æ¬çãªåæ£åªè³ªãšåè¿°ã®ãã®ããã®å¿ èŠãªä»ã®æ
åãå«æããæ» èããã¯ã«äžã«çš®ã ã®æ» èãã掻
æ§æåãå質混åããããšã«ãã€ãŠèª¿è£œãããæ»
èãã泚å°æº¶æ¶²ã調æŽããããã®æ» èç²æ«ã®å Žå
ã«ãããŠã奜ãŸãã調補æ³ã¯ç空也ç¥ããã³åçµ
也ç¥ã®æè¡ã§ããããããã«ããåè¿°ã®ããã«æ»
èéãã溶液ãã掻æ§æåãšè¿œå ã®æææåãš
ãããªãç²æ«ãåŸãããã ããã«äœ¿çšããããã«ãã補è¬åŠçã«èš±å®¹ãã
ãæ äœãã¯ä»»æã®ãã€ãã¹ãŠã®æº¶åªãåæ£åªè³ªã
被èãæ现èå€ãæçèå€ãç匵å€ããã³åžåé
延å€ãªã©ãå å«ããããã®ãããªè£œè¬åŠçç©è³ªã®
åªè³ªããã³å€ã¯ãåœåéã§ããç¥ãããŠãããåžž
çšã®åªè³ªãŸãã¯å€ã掻æ§æåãšäžé©æ§ã§ããå Žå
ãé€ããæ²»ççµæç©äžã®ãããã®äœ¿çšãèããã
ããè£å©æŽ»æ§æåãçµæç©ã«æ··å ¥ããããšãã§ã
ãã æäžã容æã§ãããã€åäžã«æäžããããããª
æäžåäœã®åœ¢æ ã«ãéçµå£çµæç©ãé åããããš
ã¯ãããšã«æå©ã§ãããããã§äœ¿çšããæäžåäœ
圢æ ãšã¯ãåŠçœ®ãã¹ãåºä¹³åç©ã®æ£è ãžã®åäžæ
äžã«é©ããç©ççã«åé¢ããåäœãæå³ããïŒå
åäœã¯ææã®æ²»çå¹æãçæããããã«èšç®ãã
åãã€ãŠæ±ºå®ããéã®æŽ»æ§ç©è³ªãå¿ èŠãªè£œè¬åŠç
æ äœãšäžç·ã«å«æãããæ¬çºæã®æ°èŠãªæäžåäœ
圢æ ã®èŠæ Œã¯ã(a) 掻æ§ç©è³ªã®åæã®ç¹æ§ããã³
åŸãããšããç¹å®ã®æ²»çå¹æãããã³(b) 身äœã®
å¥åº·ãããã«è©³ããé瀺ããããã«æãããç æ°
ã®ç¶æ ãæãããçããŠããæ£è ã«ãããç æ°ã®
åŠçœ®ã®ããã«ããã®ãããªæŽ»æ§ç©è³ªãé åæè¡ã«
åºæã®å¶éã«åŸãå€åããã€ãããã«çŽæ¥å·Šå³ã
ããã 䞻掻æ§æåã¯ã奜éœåãªãã€å¹æçãªæäžã®ã
ããæå¹éã§ãåè¿°ã®ãããªé©åœãªè£œè¬åŠçã«èš±
容ãããæ äœãšæäžåäœåœ¢æ ã«é åããããæäž
åäœåœ¢æ ã¯ãããšãã°ã䞻掻æ§æåãçŽ0.1ãçŽ
400mgã奜ãŸããçŽïŒãçŽ30mgã®éã§å«æã§ããã
æ¯çã§è¡šãããšã掻æ§ååç©ã¯äžè¬ã«çŽ0.1ãçŽ
400mgïŒmlæ äœã§ååšãããè£å©æŽ»æ§æåãå«æ
ããçµæç©ã®å Žåã«ãããŠãæäžéã¯åèšæåã®
éåžžã®æäžéããã³æäžéãåç §ããŠæ±ºå®ãã
ãã çã®åŸéããã³ç·©åã¯ãããšãã°ãè ¹è å æäž
ãçšããŠãéæããããåäžã®éèå æäžãŸãã¯
å埩ããæ¯æ¥ã®æäžãè¡ãããšãã§ãããçŽïŒã
10æ¥ãŸã§ã®æ¯æ¥ã®æäžã¯ãã°ãã°ååã§ããããŸ
ãæ¯æ¥ïŒåã®æäžãŸãã¯ïŒåã®æäžãïŒæ¥çœ®ããŸ
ãã¯ããããå°ãªãé »åºŠã®æ¥ã«åé ããããšãã§
ãããæäžé€çæ³ããæãããªããã«ãæäžãã
䞻掻æ§æåã¯ãçãå容ãã宿䞻ã«å¯ŸããŠçŽ°èæ¯
æ§ã®é床ã®æªãå¯äœçšã®ååšã§ãçœè¡ç ãªã©ã®åŸ
éããã³ç·©åãå©ããã®ã«ååãªéã§ãããçã®
ç æ°ã¯çœè¡ç ã®ãããªè¡æ¶²ã®æªæ§è «çãªãã³ã«è²
æ¯çãèºçããã³ä¹³çã®ãããªä»ã®å å®æ§ããã³
éå å®æ§ã®æªæ§è «çãæå³ãããåŸéããã³ç·©å
ã¯ãåŠçœ®äžååšã®ç æ°ã®é²è¡ã«æ¯ã¹ãŠãè «çã®æ
é·ãŸãã¯ä»ç æ°ã®çºçŸãé»æ¢ãŸãã¯é 延ããããš
ãæå³ããã æ¬çºæãã次ã®ç¹å®ã®å®æœäŸã«é¢é£ããŠããã
ã«è©³ãã説æããã å®æœäŸ ïŒ ïŒïŒ1â²âãã€ãããã¹ïŒãšãã¬ã³ã€ããâãšã
ã¬ã³ã€ããïŒããã¹ãïŒïŒïŒâãžããããã·â
ïŒâããïŒâïŒïŒâããããã·ãšãã«ã¢ããïŒãš
ãã«ãã¢ãããã¢ã³ã¹ã©ããã³ãããã©ããã
ã¯ãã©ã€ã ïŒâã¡ããã·ãšã¿ããŒã«ïŒ280mlïŒããããŸã
ãªãã15åéã®çªçŽ ã®æ³¡ç«ãŠéå ¥ã«ããè±æ°ãã
次ãã§10.97ïœïŒ0.04ã¢ã«ïŒã®ãã€ã³ïŒïŒïŒïŒïŒïŒ
ïŒâããã©ããããã·ã¢ã³ã¹ã©ããã³ãå ããã
ããŠçªçŽ é°å²æ°äžã§ãããŸãã25âã§ïŒæéç¶ã
ãããã®æ··åç©ã氷济äžã§ïŒåéå·åŽãã次ãã§
3.786ïœïŒ0.02ã¢ã«ïŒã®åèžçããããã©ãšãã¬
ã³ãã³ã¿ãã³ïŒå転ãã©ã·å¡äžã§åçããïŒæ²žç¹
185âïŒïŒmmHgïŒããããŸããæ··åç©ã«çªçŽ é°å²
æ°äžã§ç®äžæ³šå°åšããïŒåéã«ããã滎ã å ã
ãããã®æ··åç©ãïŒæéãããŸãããã®é枩床ã¯
ïŒâãã22âã«å¢å ãã次ãã§å ç±ããªã油济ã«
å ¥ãããçªçŽ é°å²æ°äžã§ç¶ãããã®é济ã®æž©åºŠã
50âã«åŸã ã«äžæãã次ãã§æ··åç©ã50âã§ãã
ã«ïŒæéå ç±ãããïŒâïŒïŒâã¢ãããšãã«ã¢ã
ãïŒãšã¿ããŒã«ïŒ4.166ïœã0.04ã¢ã«ïŒããæ··å
ç©ã«ç®äžæ³šå°åšã§å ãããçªçŽ é°å²æ°äžã§ãããŸ
ãããã³å ç±ã15æéç¶ããããã®åå¿æ··åç©ã
å·åŽããããã€ã³åœ¢ã®çæç©ã®çããæžæ¿æ¶²ã
10.01ïœïŒ0.0408ã¢ã«ïŒã®ã¯ãã©ãã«ãæ·»å ãã
ãã®æ··åç©ã氷济äžã§å·åŽããªãã25.0mlã®8N
ãšã¿ããŒã«æ§å¡©åæ°ŽçŽ ã滎ã å ãã次ãã§å·åŽã
ãããšãªã15æéãããŸããããšã«ããé žåã
ããçããæ··åç©ãé å¿åé¢ããåºäœãïŒåãã
ã©ããããã©ã³ã§æŽããéããŠ20.19ïœã®æé
è²åºäœãåŸããåºäœã15æé宀枩ã«ãããŠ360ml
ã®æ°Žãšäžç·ã«ãããŸããããã®æº¶æ¶²ã30åé17ïŒ
000Gã§é å¿åé¢ãã次ãã§ãã«ã³ãããéã
ããçæç©ãã5.9mlã®12.2Nå¡©é žã®æ·»å ã«ããé ž
æ§ã«ããããšã«ããã液ããåæ²æ®¿ããããã®
æ··åç©ã18ïŒ000Gã§25åéé å¿åé¢ãããçã
ãåºäœãé«éãããŸãæ©ã§åæ£ã«ããåå350ml
ã®0.2Nå¡©é žã§ïŒåæŽæµãã次ãã§17000Gã§é å¿
åé¢ãã次ãã§ãšã¿ããŒã«ã§ïŒåæŽæµããéã«
ãã8.56ïœã®ãã®å®æœäŸã®çæç©ãæéè²åºäœãš
ããŠåŸãïŒU.V.ïŒH2Oã10.31mcg.ïŒmlïŒ240nm
ïŒÎµ60ïŒ200ïŒã275ïŒ20ïŒ400ïŒã564shïŒ17ïŒ400ïŒã
609ïŒ28ïŒ100ïŒã660shïŒ20ïŒ400ïŒããããâã¹ããŒ
ãžïŒhotâstageïŒé¡åŸ®é¡ãçšããŠèŠ³å¯ããè©Šæã¯
350âãŸã§æº¶èããªããã·ãªã«ã²ã«ãçšããèå±€
ã¯ãããã°ã©ãã€ãŒãè¡ãã0.2ã¢ã«ã®æ°Žæ§ã¯ãš
ã³é žãã¢ã»ããããªã«ããã³é ¢é žã60ïŒ40ïŒïŒã®
äœç©æ¯ã§çšãããšãRf0.0ã«çæç©ã瀺ãããã
ãŠäžã®åæããã®èããããå¯çç©ã§ããä»ã®æ
è «çæ§ååç©ãïŒïŒïŒâãžããããã·âïŒïŒïŒâ
ãã¹âãïŒâãïŒâïŒïŒâããããã·ãšãã«ïŒã¢ã
ãããšãã«ãã¢ããâïŒïŒ10âã¢ã³ã¹ã©ã»ã³ãžãª
ã³ãžãããã¯ããªãïŒRf0.4ïŒã瀺ããªãã€ãã
åŸè ã®ååç©ïŒMurdockïŒet alïŒïŒlocïŒcitïŒïŒ
ã¯ãæ¬çºæã®çæç©ãšç°ãªããçäœç©ã®12Nå¡©é ž
ãå ããŠããã氎溶液ããæ²æ®¿ããªãã å®æœäŸ ïŒ ãã€ã³ïŒïŒ1â²âãã€ãããã¹ïŒãšãã¬ã³ã€ãã
âãšãã¬ã³ã€ããïŒããã¹ãïŒïŒïŒâãžããã
ãã·âïŒâããïŒâïŒïŒâããããã·ãšãã«ã¢ã
ãïŒãšãã«ãã¢ãããã¢ã³ã¹ã©ããã³ å®æœäŸïŒã®æé ãå埩ãããããã ããã€ã³å
ã®çæç©ãé žæ§ã«ãããããã¯ã¯ãã©ãã«ã§é žå
ããªãã§ãé å¿åé¢ã«ããéãããšã¿ããŒã«ã§æŽ
æµããŠãæšé¡ååç©ãèµ€ãã€è²åºäœãšããŠåŸãã å®æœäŸïŒã®æšé¡ååç©ã®ãã€ã³äœã«çžåœããã
ã®çæç©ã¯ã350âãŸã§æº¶èãããå®æœäŸïŒã®å
åç©ã®U.Vã¹ãã¯ãã«ã«é ·äŒŒããU.Vã¹ãã¯ãã«
ãäžããã å®æœäŸ ïŒ ïŒïŒ1â²âããšãã¬ã³ãã¹ïŒã€ãããšãã¬ã³ã€ã
ãïŒããã¹ãïŒïŒïŒâãžããããã·âïŒâããïŒ
âïŒïŒâããããã·ãšãã«ã¢ããïŒãšãã«ãã¢
ãããã¢ã³ã¹ã©ããã³ããã©ãããã¯ãã©ã€ã å®æœäŸïŒã®æé ãå埩ããããããã©ãšãã¬ã³
ãã³ã¿ãã³ã®ä»£ããã«2.925ïœã®ããªãšãã¬ã³ã
ãã©ãã³ã䜿çšãããšã1.86ïœã®ææçæç©ãé
é»è²åºäœãšããŠåŸããããm.p.ïŒ350âã å®æœäŸ ïŒ ïŒïŒ1â²âããªã¯ã¿ã¡ãã¬ã³ãžã€ããïŒãã¹ãïŒïŒ
ïŒâãžããããã·âïŒâããïŒâïŒïŒâãããã
ã·ãšãã«ã¢ããïŒãšãã«ãã¢ãããã¢ã³ã¹ã©ã
ãã³ããžãããã¯ãã©ã€ã å®æœäŸïŒã®çž®åããã³é žåæé ãå€æŽããŠãã
ãã©ãšãã¬ã³ãã³ã¿ãã³ã®ä»£ããã«ã10mlã®ïŒâ
ã¡ããã·ãšã¿ããŒã«äžã®2.88ïœã®ïŒïŒïŒâãžã¢ã
ããªã¯ã¿ã³ã®æº¶æ¶²ãçšãããé žåãããæ··åç©ã
é å¿åé¢ããæ²éããåºäœãããã©ããããã©ã³
ã§éã«ããïŒåæŽæµãããããã400mlã®0.6N
å¡©é žäžã«æžæ¿ãã18ïŒ000ïœã§é å¿åé¢ãããã
ã®ãã¬ããã1Nå¡©é žäžã«ïŒååæ£ãã17ïŒ000G
ã§é å¿åé¢ã«ããæŽæµãã次ãã§é å¿åé¢ã«ãã
ãšã¿ããŒã«ã§æŽæµããæåŸã«é å¿åé¢ã«ããã¢ã»
ãã³ã§æŽæµãããšã11.08ïœã®ãã®å®æœäŸã®çæ
ç©ãéé»è²åºäœãšããŠåŸããããm.p.180â185
âã å®æœäŸ ïŒ ïŒïŒ1â²âãã€ãããã¹ïŒãšãã¬ã³ã€ããïŒããã¹
ãïŒïŒïŒâãžããããã·âïŒâããïŒâïŒïŒâãã
ããã·ãšãã«ã¢ããïŒãšãã«ãã¢ãããã¢ã³ã¹
ã©ããã³ãããªãããã¯ãã©ã€ã ããã©ãšãã¬ã³ãã³ã¿ãã³ã®ä»£ããã«2.06ïœã®
ãžãšãã¬ã³ããªã¢ãã³ãçšããå®æœäŸïŒã®çž®åã
ãã³é žåãè¡ããšã17.15ïœã®æšé¡ååç©ãéé»
è²åºäœãšããŠåŸããããããã¯215â以äžã§çŒçµ
ãããããã¯æ¬è³ªçã«æ°Žäžæº¶æ§ã§ããã å®æœäŸ ïŒ ïŒïŒ1â²âãããªã¡ãã¬ã³ãã¹ïŒã€ãããšãã¬ã³
ã€ããïŒããã¹ãïŒïŒïŒâãžããããã·âïŒâ
ããïŒâïŒïŒâããããã·ãšãã«ã¢ããïŒãšãã«ã
ã¢ãããã¢ã³ã¹ã©ããã³ãããã©ãããã¯ãã©
ã€ã å®æœäŸïŒã®æé ãå埩ããŠãããã©ãšãã¬ã³ã
ã³ã¿ãã³ã®ä»£ããã«3.20ïœã®ïŒ®ïŒNâ²âãã¹ïŒïŒâ
ã¢ãããšãã«ïŒâïŒïŒïŒâãããã³ãžã¢ãã³ïŒå
çãããã®ïŒæ²žç¹190âïŒ50mmïœïŒã䜿çšããã
ãã®çæç©ã¯1.93ïœã®éé»è²åºäœã§ãããm.p.ïŒ
350âã§ããã å®æœäŸ ïŒ ïŒïŒ1â²âãïŒâãããã¬ã³ãã¹ïŒã€ãããšãã¬
ã³ã€ããïŒããã¹ãïŒïŒïŒâããããã·âïŒâ
ããïŒâïŒïŒâããããã·ãšãã«ã¢ããïŒãšãã«ã
ã¢ãããã¢ã³ã¹ã©ããã³ãããã©ãããã¯ãã©
ã€ã å®æœäŸïŒã®çž®åããã³é žåã®æé ãå€æŽããŠã
ããã©ãšãã¬ã³ãã³ã¿ãã³ã®ä»£ããã«3.44ïœã®
ïŒNâ²âãã¹ïŒïŒâã¢ãããšãã«ïŒâïŒâããã³
âïŒïŒïŒâãžã¢ãã³ïŒåçãããã®ïŒæ²žç¹169
âïŒïŒmmïœïŒã䜿çšãããç²è£œã®é žåçæç©ã¯
11.81ïœã®éé»è²åºäœã§ããã360mlã®æ°Žäžã®ãã®
åºäœã15åéãããŸããããã®æº¶æ¶²ã18ïŒ000G
ã§é å¿åé¢ããéããã液ã5.9mlã®12.3Nå¡©
é žã§0.2Nã«é žæ§ã«ããçãã綿ç¶ã®åºãŸãã®æž
æ¿æ¶²ã18ïŒ000Gã§é å¿åé¢ãããäžæŸã¿æ¶²ãã
ã«ã³ãããéããã液ã5.9mlã®12.3Nå¡©é žã§
0.4Nã«é žæ§ã«ããé å¿åé¢ãããäžæŸæ¶²ããã«
ã³ãããæ®çåºäœããšã¿ããŒã«ã§ïŒåæŽæµããŠã
161ïœã®ãã®å®æœäŸã®çæç©ãæéè²åºäœãšããŠ
åŸãm.p.ïŒ350âã å®æœäŸ ïŒ ïŒïŒ1â²âãããã©ã¡ãã¬ã³ãã¹ïŒã€ãããšãã¬
ã³ã€ããïŒããã¹ãïŒïŒïŒâãžããããã·âïŒ
âããïŒâïŒïŒâããããã·ãšãã«ã¢ããïŒãšã
ã«ãã¢ãããã¢ã³ã¹ã©ããã³ãããã©ãããã¯
ãã©ã€ã 100mlã®ãšã¿ããŒã«äžã®12.00ïœã®åçããïŒ
Nâ²âãã¹ïŒïŒâã¢ãããšãã«ïŒâïŒâããã³â
ïŒïŒïŒâãžã¢ãã³ïŒæ²žç¹169âïŒïŒmmïœïŒã®æº¶
液ããããŒã«ïŒParrïŒåæ°ŽçŽ ååšå ã§60psiïŒ4.2
KgïŒcm2ïŒã®åææ°ŽçŽ å§ã«ãããŠ2.00ïœã®ã©ããŒã
ãã±ã«è§Šåªã®ååšã§19âã§ïŒæéæ¯ãšãããã溶
液ãéãã次ãã§å転ãã©ã·å¡äžã§åçãã
ãšã9.19ïœã®ïŒ®ïŒNâ²âãã¹ïŒïŒâã¢ãããšãã«ïŒ
âïŒïŒïŒâãã¿ã³ãžã¢ãã³ãåŸãããã沞ç¹161
â162âïŒïŒmmïœã ããã©ãšãã¬ã³ãã³ã¿ãã³ã®ä»£ããã«3.49ïœã®
ãã®ããªã¢ãã³ãçšãããšã2.91ïœã®æšé¡ååç©
ãæéè²åºäœãšããŠåŸãããããã¯205âããã
ããã«çŒçµãããã350âãŸã§æº¶èããªãã å®æœäŸ ïŒ ïŒïŒ1â²âãããã©ã¡ãã¬ã³ãã¹ïŒã€ããããªã¡
ãã¬ã³ã€ããïŒããã¹ãïŒïŒïŒâãžããããã·
âïŒâããïŒâïŒïŒâããããã·ãšãã«ã¢ããïŒ
ãšãã«ãã¢ãããã¢ã³ã¹ã©ããã³ãããã©ãã
ãã¯ããªã å®æœäŸïŒã®æé ã¯ïŒåã®ïŒèŠæš¡ã§å埩ãããã
ã©ãšãã¬ã³ãã³ã¿ãã³ã®ä»£ããã«2.02ïœã®ã¹ãã«
ãã³ã䜿çšãããææçæç©ã¯1.87ïœã®æéè²åº
äœãšããŠåŸããããèç¹çŽ190â199âã å®æœäŸ 10 ïŒïŒ1â²âããšãã¬ã³ãã¹ïŒã€ãããšãã¬ã³ã€ã
ãïŒããã¹ãïŒïŒïŒâãžããããã·âïŒâãïŒïŒ
âã¡ãã¬ã³ã¢ãããšãã«ïŒã¢ãããã¢ã³ã¹ã©ã
ãã³ãããã©ãããã¯ãã©ã€ã åçããããªãšãã¬ã³ããã©ãã³2.92ïœïŒæ²žç¹
140âïŒïŒmmïœãn20 D1.4981ïŒããã³2.96ïœã®ïŒ®
âã¡ãã¬ã³ãžã¢ãã³ããå®æœäŸïŒã®æé ã«ãã
ãŠãããããããã©ãšãã¬ã³ãã³ã¿ãã³ããã³ïŒ
âïŒïŒâã¢ãããšãã«ã¢ããïŒãšã¿ããŒã«ã®ä»£ã
ãã«äœ¿çšãããæ°Žæ§æœåºæ¶²ããã®çæç©ã®å¹æç
ãªåæ²æ®¿ã¯ã11.8mlã®12.3Nå¡©é žãçšãã0.4Nãž
ã®é žçåããã³åŒãç¶ã17ïŒ000Gã«ãããé å¿
åé¢ã«ããéæããããåŸãããåºäœã¯é å¿åé¢
ã«ããåå150mlã®0.4Nå¡©é žã§ïŒåãéã«ãã
ãšã¿ããŒã«ã§ïŒåããããŠéã«ããã¢ã»ãã³ã§
ïŒåãããããæŽæµãããšã6.50ïœã®ææçæç©
ãæéè²åºäœãšããŠåŸããããm.p.ïŒ350âãïŒ
U.V.ïŒH2Oã9.31mcg.ïŒmlïŒïŒÎ»max235nmïŒÎµ56ïŒ
300ïŒ274shïŒ19ïŒ800ïŒã608ïŒ23ïŒ600ïŒã658shïŒ15ïŒ
100ïŒã å®æœäŸ 11 ïŒïŒ1â²âããšãã¬ã³ãã¹ïŒã€ãããšãã¬ã³ã€ã
ãïŒããã¹ãïŒâããïŒâïŒïŒâããããã·ãšãã«
ã¢ããïŒãšãã«ãã¢ãããã¢ã³ã¹ã©ããã³ãã
ãã©ãããã¯ããªã åçããããªãšãã¬ã³ããã©ãã³2.92ïœïŒæ²žç¹
140âïŒïŒmmïœãn20âD1.4981ïŒããã³9.69ïœã®
ãã€ã³ããã¶ãªã³ããå®æœäŸïŒã®æé ã«ãããŠã
ããããããã©ãšãã¬ã³ãã³ã¿ãã³ããã³ãã€ã³
ïŒïŒïŒïŒïŒïŒïŒâããã©ããããã·ã¢ã³ã¹ã©ãã
ã³ã®ä»£ããã«äœ¿çšãããç²è£œã®é žåããçæç©ã®
æ°Žæ§æœåºæ¶²ãã11.8mlã®12.3Nå¡©é žã§0.4Nã®é žç
åã«ãã次ãã§17ïŒ000Gã§é å¿åé¢ãããäžæŸ
ã¿æ¶²ããã«ã³ããããããŠéããã液ã11.8
mlã®12.3Nå¡©é žã§0.8Nã«é žæ§ã«ããäžã®ããã«é
å¿åé¢ãããäžæŸã¿æº¶æ¶²ããã«ã³ãããæ®çç©ã
é å¿åé¢ã«ããåå50.0mlã®0.8Nå¡©é žã§æŽæµãã
次ãã§ãšã¿ããŒã«ã§éã«ããïŒåæŽæµãããšã
2.61ïœã®ãã®å®æœäŸã®çæç©ã玫é»è²åºäœãšããŠ
åŸããããm.p.175â180âïŒU.V.ïŒH2Oã
12.36mcg.ïŒmlïŒïŒÎ»max253nmïŒÎµ56ïŒ300ïŒ327
ïŒïŒïŒ000ïŒã552shïŒ15ïŒ400ïŒã582ïŒ18ïŒ400ïŒã
626shïŒ11.900ïŒ å®æœäŸ 12 ãè¡šã ïŒïŒ1â²âãã€ãããã¹ïŒãšãã¬ã³ã€ããïŒããã¹
ãïŒïŒïŒâãžããããã·âïŒâããïŒâïŒïŒâããã
ãã·ãšãã«ã¢ããïŒãšãã«ãã¢ãããã¢ã³ã¹ã©ã
ãã³ãããã©ãããã¯ãã©ã€ããã©ã¯ããŒã¹ãã
ã³ã³ãŒã³ã¹ã¿ãŒãïŒæ··åç©çšïŒãäžç·ã«é åã
ããã³ãŒã³ã¹ã¿ãŒãïŒããŒã¹ãçšïŒã600mlã®æ°Ž
äžã«æžæ¿ãããããŸããªããå ç±ããŠããŒã¹ãã
圢æããã次ãã§ãã®ããŒã¹ãã䜿çšããŠæ··åã
ãç²æ«ãé ç²ãããè¿œå ã®æ°Žãå¿ èŠã«å¿ãæ··åã
ãããã®æ¹¿ã€ãç²äœãNo.ïŒã®ææã¡ãµããã«é
ãã120ãïŒ48.9âïŒã§ä¹Ÿç¥ããã次ãã§ä¹Ÿç¥ã
ãç²äœãNo.16ãµããã«éãããã®æ··åç©ãïŒïŒ ã®
ã¹ãã¢ãªã³é žãã°ãã·ãŠã ã§æœ€æ»ãããããŠé©åœ
ãªé å€åœ¢ææ©ã§é å€ã«ãã¬ã¹ããã å®æœäŸ 13 éçµå£æº¶æ¶²ã®èª¿è£œ 泚å°çšã®700mlã®ãããã¬ã³ã°ãªã³ãŒã«ããã³
200mlã®æ°Žã®æº¶æ¶²äžã«ã20.0ïœã®ïŒïŒ1â²âãã€ãã
ãã¹ïŒãšãã¬ã³ã€ããâãšãã¬ã³ã€ããïŒããã¹
ãïŒïŒïŒâãžããããã·âïŒâããïŒâïŒïŒâããã
ãã·ãšãã«ã¢ããïŒãšãã«ãã¢ãããã¢ã³ã¹ã©ã
ãã³ãããã©ãããã¯ãã©ã€ãããããŸããªãã
æžæ¿ãããæžæ¿ãå®çµåãPHãå¡©é žã§5.5ã«èª¿æŽ
ããäœç©ã泚å°çšã®æ°Žã§1000mlã«ããã調補ç©ã
æ» èãã5.0mlã®ã¢ã³ãã«ã«å å¡«ããåã¢ã³ãã«
ã¯2.0mlïŒ40mgã®è¬ç©ãè¡šããïŒãå«æããçªçŽ
é°å²æ°äžã§å¯éããã å®æœäŸ 14 ïŒïŒ1â²âïŒãšãã¬ã³ãžã€ããïŒãã¹ãïŒâïŒïŒâ
ã¢ãããšãã«ïŒã¢ãããïŒïŒïŒâãžããããã·
ã¢ã³ã¹ã©ããã³ãžãããã¯ããªã 160mlã®ïŒ®ïŒïŒ®ïŒNâ²ïŒNâ²âããã©ã¡ãã«ãšãã¬
ã³ãžã¢ãã³äžã®14.44ïœã®ãšãã¬ã³ãžã¢ãã³ã®æº¶
液ãããããŸããªããçªçŽ ã泡ç«ãŠãŠ15åééå ¥
ããŠè±æ°ããã41.94ïœã®ãã€ã³ïŒïŒïŒïŒïŒïŒïŒ
âããã©ããããã·ã¢ã³ã¹ã©ããã³ãå ããåŸã
ãã®æ··åç©ãçªçŽ é°å²æ°äžã§25âã«ãããŠïŒæé
ãããŸãã次ãã§48â50âã®æ²¹æµŽã§å ç±ããªãã
ããã«ïŒæéãããŸããããã®æ··åç©ãå·åŽãã
åºäœãéã«ããéãããšã¿ããŒã«ã§æŽæµããŠã
28.25ïœã®ç·é»è²åºäœãåŸãããã®ããã€ã³ãä»
å ç©ããå®æœäŸïŒã«ãããããã«ã14.4mlã®8N
ãšã¿ããŒã«æ§å¡©åæ°ŽçŽ ãå«æãã565mlã®ïŒâã¡
ããã·ãšã¿ããŒã«ã§19.77ïœã®ã¯ãã©ãã«ã«ãã
é žåãããåºäœãéã«ããéããããã©ããã
ãã©ã³ã§æŽæµãããšã29.66ïœã®éé»è²åºäœãåŸ
ãããããã®åºäœã¯æ°Žæº¶æ§å¯çç©ã®ïŒïŒïŒâãã¹
ïŒïŒâã¢ãããšãã«ã¢ããïŒâïŒïŒïŒâãžãããã
ã·ã¢ã³ã¹ã©ããã³äºå¡©é žå¡©ãå«æããããã800
mlã®æ°Žãšãšãã«14æéãããŸããé å¿åé¢ãã次
ãã§åºäœãé å¿åé¢ã«ããæŽæµããããšã«ãã€
ãŠãé€å»ãããäžæŽ»æ§ã®éé»è²åºäœïŒ6.8ïœïŒã¯
æšé¡ååç©ã§ãããããã¯350âãŸã§æº¶èããªãã
ããã¯ãäžè¬åŒ åŒäžã âã¯ãâCH2âCH2âãŸãã¯âCHïŒCHâ
ã§ããïŒ ïŒ±ã¯ãâCH2CH2NHâCH2CH2OHãâ
CH2CH2NHâCH2CH2NH2ãŸãã¯â
CH2CH2NHâCH2CH2NHCH3ã§ããïŒãã
㊠ã¯ãâïŒCH2ïŒïœâãããã§ïœã¯ïŒãïŒã®æŽæ°
ã§ãããâCH2CH2NHâCH2CHïŒCHCH2NH
âCH2CH2âã âïŒCH2ïŒ3NHâïŒCH2ïŒ4NHâïŒCH2ïŒ3âãâ
CH2CH2âïŒNHCH2CH2ïŒïœâãããã«ïœã¯
ïŒãïŒã®æŽæ°ã§ããããŸãã¯âCH2CH2NHâ
ïŒCH2ïŒïœâNHCH2CH2âãããã« ïœã¯ïŒãïŒã®æŽæ°ã§ããã ã§è¡šããããšãã§ããæ°èŠãªãããã¢ã«ãã¬ã³ã
ã¹ã¢ã³ã¹ã©ããã³é¡ïŒããã³è£œè¬åŠçã«èš±å®¹ãã
ããããã®é žåå å¡©ã«é¢ããã ãŸããæ¬çºæã®ç¯å²å ã«ã¯ã次ã®äžè¬åŒã§è¡šã
ãããšãã§ãããã€ã³å¡©åºããã³äºå€ç°æ§äœãå
å«ãããïŒ åŒäžïŒ±ããã³ïŒ¡ã¯äžã«å®çŸ©ãããšããã§ããã æè¿ãK.C.MurdockïŒet alïŒïŒJ.Med.Chem.ïŒ
22ïŒ1024ïŒ1979ïŒã¯ãæž©è¡åç©ã«ãããŠæç掻æ§
ã瀺ãäžçŸ€ã®ïŒïŒïŒâãã¹ãïŒã¢ããã¢ã«ãã«ïŒ
ã¢ãããã¢ã³ã¹ã©ããã³é¡ãåæããããããã®
ååç©ã®ããã€ããããã«ç 究ããããããã¯ã
ãªãã·ãªãæ žé žïŒDNAïŒã®æ žé žããŒã¹ã®é£ç¶ã
ã察ã®éã«ã¯ããŸããããšã«ãããDNAã«çµå
ããããšã瀺ããããJohnsonïŒet alïŒïŒ
Cancer Treatment ReportsïŒ63ïŒ425ïŒ1979ïŒãã
ãã®åã®DNAãžã®ããçš®ã®å¹³ããªå€ç°åŒè³éŠæ
ååã®ããå ¥çµåã¯å ¥ããã¿ïŒintercalationïŒãš
åŒã°ãããŸãããçš®ã®ä»ã®è¬ç©ã®ç¹è²ã§ããã
ãSchwartzïŒBiomedicineïŒ24ïŒ317ïŒ1976ïŒãã äžã®J.MedïŒChem.ã®æç®ã«èšèŒãããŠããå
åç©ãªãã³ã«æ¬çºæã®ååç©ã®äœçšã®æ©æ§ã¯ç«èšŒ
ãããŠããªãããçºæè ãã®äºæž¬ã«ãããšãé©åœ
ãªå¡©åºæ§åŽéãæããã¢ã³ã¹ã©ããã³æ žã¯ç现è
ã®DNAäžã«å ¥ãããããšãã§ããããããç现
èã®å¢æ®ãé»æ¢ããããã«é©åœãªçµååäœã«ãã€
ãŠçµåããããïŒã€ã®ãã®ãããªã¢ã³ã¹ã©ããã³
ç³»ã¯åãDNAéã®ïŒã€ã®äœçœ®ã®äžã«å ¥ãããã
ãšãã§ããããã«ãã€ãŠãã倧ãã匷ãããã³èœ
åããã€ãŠçµåããããšãã§ããããããã¯ãã
ã®ãããªäºéã®çµåããªãã¡ãã¹âã€ã³ã¿ãŒã«ã¬
ãŒã·ãšã³ïŒbisâintercalationïŒã¯åžžæ ã§äºéã®
ã¹ãã©ã³ãåããDNAã®é£æ¥ã¹ãã©ã³ããçµå
ããããã«ãã€ãŠãDNAã®è€è£œããã³çŽ°èã®å¢
æ®ã«å¿ èŠã§ããããšãç¥ãããŠãããã¹ãã©ã³ã
ã®åé¢ãé²ãããšãã§ããããŸãããã®ãããªäº
éåããã¢ã³ã¹ã©ããã³ã®äžç«¯ãŸãã¯äž¡ç«¯ãä»ã®
现èæåãããšãã°ã现èèãããã³ã³ããªã¢ã
ãªã³èèªè³ªãŸãã¯ããã±ã質ãžçµåããå Žåãå¢
æ®ã¯åæ§ã«åŠšå®³ãããã äœçšã®çååŠçæ©æ§ã¯ç¢ºç«ãããŠããªããã以
äžã«è©³è¿°ããçºæã¯çãæããããŠã¹ã®å¯¿åœãå®
質çã«å»¶é·ããäžç³»åã®ãã¹ã¢ã³ã¹ã©ããã³é¡ã
èšèŒããã æ¬çºæã®æ°èŠãªååç©ã¯ãç¹åŸŽããèç¹ãšåžå
ã¹ãã¯ãã«ãæããèµ€å³ãã€è²ãªããéé»è²åºäœ
ãšããŠåŸãããšãã§ãããããŠéé¢å¡©åºã®å€ãã¯
æ°ŽäžæŽ»æ§ã§ããããããŠãããã®ãããã®ã¯å€§ãŠ
ãã®ææ©æº¶åªã«äžæŽ»æ§ã§ããã®ã§ãäœçŽã¢ã«ã«ã
ãŒã«ã§æµžåºããããšã«ãã粟補ã§ãããæ¬çºæã®
ææ©å¡©åºïŒãããã³ïŒã¯ãçš®ã ã®è¬çåŠç
ã«èš±å®¹ãããææ©ããã³ç¡æ©ã®å¡©åœ¢æè©Šè¬ãšé žå
å å¡©ã圢æãããããããŠãææ©å¡©åºãšé žãšãã
é©åœã«ã¯äžæ§æº¶åªäžã§ãæ··åããããšã«ãã圢æ
ãããé žåå å¡©ã¯ãç¡«é žããªã³é žãå¡©åæ°ŽçŽ é žã
èåæ°ŽçŽ é žãã¹ã«ãã¢ãã³é žãã¯ãšã³é žãä¹³é žã
ãªã³ãŽé žãã³ãã¯é žãé ç³é žãé ¢é žãã°ã«ã³ã³
é žãã¢ã¹ã³ã«ãã³é žãªã©ã®ãããªé žã§åœ¢æãã
ããæ¬çºæã®ç®çã«å¯ŸããŠãéé¢å¡©åºã¯ãããã®
é žä»å å¡©ãšåçã§ãããæ¬çºæã®ææ©å¡©åºã®é žä»
å å¡©ã¯åºäœã§ããããããã®ã»ãšãã©ã¯æ°Žã«æ¯èŒ
ç溶ãããããã¹ãŠã¯é極æ§ææ©æº¶åªãããšãã°
ãžãšãã«ãšãŒãã«ããã³ãŒã³ããã«ãšã³ãªã©ã«æ¯
èŒçäžæº¶æ§ã§ããã æ¬çºæã®æ°èŠãªååç©ã¯ã次ã®åå¿ã«åŸã容æ
ã«è£œé ã§ããïŒ åŒäžïŒ¡ããã³ïŒ±ã¯äžã«å®çŸ©ãããšããã§ããã
ãã®åå¿ã«åŸããšããã€ã³ïŒïŒïŒïŒïŒïŒïŒâãã
ã©ããããã·ã¢ã³ã¹ã©ããã³ãŸãã¯ãã€ã³ããã¶
ãªã³ïŒïŒãé©åœãªãããã¢ã«ãã¬ã³ãžã¢ãã³
ïŒïŒãšçªçŽ ãµãå²æ°ã®ããšã«ïŒâã¡ããã·ãšã¿
ããŒã«ããšã¿ããŒã«ããžã¡ãã«ãã«ã ã¢ãããªã©
ã®ãããªæº¶åªäžã§ïŒâã50âã«ãããŠïŒã15æé
ãããŸããŠãåå¿ããïŒïŒ1â²âãã¹ãã€ã³äžéå
åç©ïŒïŒãçæãããïŒâã¡ããã·ãšã¿ããŒã«
äžã®äžéäœïŒïŒãé©åœãªã¢ã«ãã¬ã³ãžã¢ãã³
ïŒïŒãšçŽ40âãçŽ60âã«ãããŠçªçŽ ã®ãµãå²æ°
ã®ããšã«æ°æéçž®åããŠã察å¿ãããã€ã³å¡©åº
ïŒïŒãçæãããäžéäœïŒïŒãŸãã¯ãã€ã³å¡©
åºïŒïŒã®ããããåé¢ããå¿ èŠã¯ãªãããã€ã³
å¡©åºïŒïŒã®å®å šã«è³éŠæã®èªå°äœïŒïŒãžã®é ž
åã¯ãçš®ã ã®æ¹æ³ãããšãã°ã空æ°é žåãç±ãã
ããã³ãŒã³ã«ããåŠçãé žäžã®ã¯ãã©ãã«ã«ãã
åŠçããããã¯éé žåæ°ŽçŽ ãŸãã¯éããŠçŽ é žãã
ãªãŠã ã«ããåŠçã«ããã容æã«å®æœã§ãããé
é žæ§ã®é žåç³»ãçšããå Žåãå·åŽããæ··åç©ã次
ã«é žæ§åãããéãããšãé žåçæç©ã®å¡©ãåŸ
ãããããã®å¡©ã®ç²Ÿè£œã¯ããããæ°Žäžã«æº¶è§£ãã
äžæŽ»æ§æ±æç©è³ªãé å¿åé¢ãã次ãã§é žæ§åºŠã
0.2ãªãã0.8Nã®ç¯å²ã®é žäŸ¡ã«äžããŠåæ²æ®¿ãã
ããšã«ãã€ãŠãå®æœã§ããã粟補ã¯èå±€ã¯ããã
ã°ã©ãã€ãŒã«ããç£èŠãããïŒå¡©ã¯å¡©å¿ã«ããæ²
éãããã€åžé žã§æŽæµãã次ãã§ã¢ã«ã³ãŒã«ãã
ã³ïŒãŸãã¯ã¢ã»ãã³ã§æŽæµããã ããã«èšèŒããæ°èŠãªååç©ã¯ããã¬ãŒãå
å€ãé¯åå€ãŸãã¯éå±ã€ãªã³å°éå€ãšããŠæçšã§
ãããå€äŸ¡éå±ãšåœ¢æããé¯å¡©ã¯ãšãã«å®å®ã§ã
ãããããã®æ§è³ªã«ããããããã®ååç©ã¯ãé
å±ã€ãªã³ãåé¡ãèµ·ããçš®ã ã®ç®çã«æçšã§ã
ããããšãã°ã飜åããã³äžé£œåã®æœ€æ»æ²¹ããã³
çåæ°ŽçŽ ãèèªé žããã³ã¯ãã¯ã¹ã®ãããªçš®ã ã®
ææ©ç³»äžã®å®å®å€ãšããŠãé·ç§»éå±ã€ãªã³ã®æ±æ
ãé žåçå£åããã³çè²ãä¿é²ããå Žåã«ãã
ãŠããã¡ãããæçšã§ããããããã¯ããããã®
ç©è³ªã«ããé¯åãŸãã¯æœåºããããå€äŸ¡éå±ã®å
æã«ãããŠããŸãéå±æ äœãšããŠãããã«æçšã§
ãããéå±ã€ãªã³å°éå€ã«æ®éã®ä»ã®çšéã¯ãã
ããã®ååç©ã«ãšã€ãŠèªæã§ãããããã«ããã€
ã³å¡©åºïŒïŒã¯ãå®å šã«è³éŠæã®èªå°äœïŒïŒã®
補é ã«ãããäžéäœãšããŠæçšã§ããã ãŸããæ¬çºæã®æ°èŠãªååç©ã¯ã次ã®è©Šéšã«ã
ã確ç«ãããããã«ã移æ€ãããããŠã¹ã®è «çã®
æé·ãæå¶ããæ§è³ªãæããã ãªã³ãæ§çœè¡ç P388è©Šéš äœ¿çšããåç©ã¯ããã¹ãŠïŒã€ã®æ§ã®ãäœéãæ
å°17ïœã§ããããã¹ãŠïŒïœã®äœéç¯å²å ã®
DBAïŒïŒããŠã¹ã§ãããåè©Šéšã°ã«ãŒãã¯ïŒå¹
ãŸãã¯ïŒå¹ã®åç©ã§ãããè «çã®ç§»æ€ã¯ã106å
ã®ãªã³ãæ§çœè¡ç P388ã®çŽ°èãå«æããåžè ¹æ°Ž
æµäœã®0.5mlã®è ¹è å 泚å°ã«ãããè©Šéšååç©ã¯ã
第ïŒæ¥ç®ã第ïŒæ¥ç®ããã³ç¬¬ïŒæ¥ç®ïŒè «çã®æ¥çš®
ã«é¢ããŠïŒçš®ã ã®æäžéã§è ¹è å ã«æäžãããèŠ
åæ£ããåºæºã«åºã¥ããŠ30æ¥éãåç©ã秀éãã
çåæ°ãèšé²ãããå¹³åã®çåæéããã³åŠçœ®ã
ãåç©ïŒïŒŽïŒïŒå¯Ÿç §åç©ïŒïŒ£ïŒã®çåæéã®æ¯ã
èšç®ãããéœæ§ã®å¯Ÿç §ååç©ã¯60mgïŒKg泚å°ãšã
ãŠèšèŒããïŒâãã«ãªããŠã©ã·ã«ã§ãããæ¬çºæ
ã®ä»£è¡šçååç©ãçšãããã®è©Šéšã®çµæããè¡š
ã«èšèŒãããå¹åã®å€å®èŠæºã¯ïŒŽïŒïŒ£Ã100125
ïŒ ã§ããã ãè¡šã ãè¡šã ãè¡šã ãè¡šã é»è²è «B16 䜿çšããåç©ã¯ããã¹ãŠåäžæ§ã§ãããæå°äœ
éã17ïœã§ãããã€ãã¹ãŠãïŒïœã®äœéç¯å²å ã§
ããC57BCïŒïŒããŠã¹ã§ãããåè©Šéšã°ã«ãŒã
ã¯10å¹ã®åç©ã§ãããé»è²è «B16ã®ïŒïœã®éšåã
10mlã®å·ãããã©ã³ã¹ãã塩溶液äžã«å質混å
ãããããŠå質åç©ã®0.5mlã®ã¢ãªã³ãŒããè©Šéš
ããŠã¹ã®åã ã®è ¹è å ã«ç§»æ€ãããè©Šéšååç©
ã¯ã第ïŒæ¥ç®ãã第ïŒæ¥ç®ïŒè «çã®æ¥çš®ã«é¢ã
ãŠïŒçš®ã ã®æäžéã§è ¹è å ã«æäžãããèŠåæ£ã
ãåºæºã«åºã¥ããŠ60æ¥éãåç©ã秀éããçåæ°
ãèšé²ãããå¹³åã®çåæéããã³åŠçœ®ããåç©
ïŒïŒŽïŒïŒå¯Ÿç §åç©ïŒïŒ£ïŒã®çåæéã®æ¯ãèšç®ã
ããéœæ§ã®å¯Ÿç §ååç©ã¯20mgïŒKg泚å°ãšããŠèšèŒ
ããïŒâãã«ãªããŠã©ã·ã«ã§ãããæ¬çºæã®ä»£è¡š
çååç©ãçšãããã®è©Šéšã®çµæããè¡šã«èšèŒ
ãããå¹åã®å€å®èŠæºã¯ïŒŽïŒïŒ£Ã100125ïŒ ã§ã
ãã ãè¡šã ãè¡šã ãè¡šã ããã«ãæ¬çºæã®ç¯å²ã«ã¯ã次ã®æ§é åŒ åŒäžã âã¯ãâCH2âCH2âãŸãã¯âCHïŒCHâ
ã§ããïŒ ïŒ±ã¯ãâCH2CH2NHâCH2CH2OHãâ
CH2CH2NHâCH2CH2NH2ãŸãã¯â
CH2CH2NHâCH2CH2NHCH3ã§ããïŒãã
㊠ã¯ãâïŒCH2ïŒïœâãããã§ïœã¯ïŒãïŒã®æŽæ°
ã§ãããâCH2CH2NHâCH2CHïŒCHCH2NH
âCH2CH2âã âïŒCH2ïŒ3NHâïŒCH2ïŒ4NHâïŒCH2ïŒ3âãâ
CH2CH2âïŒNHCH2CH2ïŒïœâãããã«ïœã¯
ïŒãïŒã®æŽæ°ã§ããããŸãã¯âCH2CH2NHâ
ïŒCH2ïŒïœâNHCH2CH2âãããã« ïœã¯ïŒãïŒã®æŽæ°ã§ããïŒ ã§è¡šããããšãã§ãããããçš®ã®ãããã¢ã«ãã¬
ã³ãã¹ã¢ã³ã¹ã©ããã³é¡ïŒãŸãã¯ãããã®ãã€ã³
å¡©åºããã³é žä»å å¡©ïŒãå«æãããåºä¹³åç©ã«ã
ããçã®ç æ°ãæ¹åããã®ã«æçšãªæ²»ççµæç©ã
å å«ããããæ¬çºæã®ãã®é¢ã¯ãåºä¹³åç©ã«ãã
ãçœè¡ç ããã³é¢é£ããè «çã®åŸéããã³ïŒãŸã
ã¯ç·©åãèªçºããæ°èŠãªçµæç©ããã³æ¹æ³ãå å«
ããã æ¬çºæã®æ²»ççµæç©ã®æŽ»æ§æåããã³æ°èŠãªå
åç©ã¯ãçŽïŒmgãçŽ200mgïŒKgäœéïŒæ¥ã®ç¯å²ã®
éã§æäžãããšãã移æ€ããããŠã¹ã®è «çã®æé·
ãæå¶ãããããŠåºä¹³åç©ã«ãããçœè¡ç ããã³
é¢é£ããçã®åŸéããã³ïŒãŸãã¯ç·©åãèªçºã
ããæé©ãªçµæã®å¥œãŸããæäžé€çæ³ã¯çŽïŒmgã
çŽ50mgïŒKgäœéïŒæ¥ã§ããããããŠåèšçŽ350mg
ãçŽ3.5ïœã®æŽ»æ§ååç©ãäœéçŽ70Kgã®æ£è ã«24
æéã§æäžããããããªæäžåäœãçšããããã®
æäžé€çæ³ã¯ãæé©ãªæ²»çåŠçå¿çãåŸãããã
ãã«èª¿æŽã§ãããããšãã°ãããã€ãã«åå²ãã
éãæäžããããšãã§ããïŒæ¥ã®æäžéã¯ãæ²»ç
åŠçå Žåã®å±æ¥ã«ããå¿ èŠãšãããããã«ãæ¯äŸ
çã«æžå°ããããšãã§ããã決å®çãªå®éã®å©ç
ã¯ã掻æ§ååç©ãéèå ãçèå ãŸãã¯ç®äžã®é
çã®ãããªäŸ¿å©ãªæ¹æ³ã§æäžã§ãããšããããšã§
ããã 掻æ§ååç©ã¯ãŸãéçµå£çã«ãŸãã¯è ¹è å ã«æ
äžã§ãããéé¢å¡©åºãŸãã¯è¬çåŠçã«èš±å®¹ããã
å¡©ã®åœ¢ã®æŽ»æ§ååç©ã®æº¶æ¶²ããé©åœã«è¡šé¢æŽ»æ§
å€ãããšãã°ãããããã·ãããã«ã»ã«ããŒã¹ãš
æ··åããæ°ŽãçšããŠèª¿è£œã§ãããåæ£æ¶²ãã°ãªã»
ãªã³ã液ç¶ããªãšãã¬ã³ã°ãªã³ãŒã«ããã³ããã
ãšæ²¹ã®æ··åç©ãçšããŠèª¿è£œã§ãããéåžžã®è²¯èµã
ãã³äœ¿çšæ¡ä»¶äžã§ããããã®èª¿è£œç©ã¯åŸ®çç©ã®ç
è²ãé²æ¢ããããã«é²è å€ãå«æããã 泚å°å¯èœãªäœ¿çšã«é©åœãªè£œè¬åŠç圢æ ã¯ãæ» è
泚å°å¯èœãªæº¶æ¶²ãŸãã¯åæ£æ¶²ãåŠæ¹ç®ã«å¿ããŠèª¿
補ããããã®ãæ» èãã氎溶液ãŸãã¯åæ£æ¶²ãã
ã³æ» èããç²æ«ãå å«ããããã¹ãŠã®å Žåã«ãã
ãŠãåèšåœ¢æ ã¯æ» èããªããŠã¯ãªããããããŠæ³š
å°å®¹æã§ãããããªçšåºŠã«æµåæ§ã§ãªããŠã¯ãªã
ãªããããã¯è£œé ããã³è²¯èµã®æ¡ä»¶äžã§å®å®ã§ãª
ããŠã¯ãªããããããŠåŸ®çç©ããšãã°çŽ°èããã³
çèã®æ±æäœçšã«å¯ŸããŠä¿åãããªããŠã¯ãªããª
ããæ äœã¯ãããšãã°ãæ°Žããšã¿ããŒã«ãããªãª
ãŒã«ïŒããšãã°ãã°ãªã»ããŒã«ããããã¬ã³ã°ãª
ã³ãŒã«ãããã³æ¶²ç¶ããªãšãã¬ã³ã°ãªã³ãŒã«ãª
ã©ïŒãé©åœãªãããã®æ··åç©ãããã³æ€ç©æ²¹ãå«
æãã溶åªãŸãåæ£æ¶²ã®åªè³ªã§ããããšãã§ã
ããé©åãªæµåæ§ã¯ãããšãã°ãã¬ã·ãã³ã®ãã
ãªè¢«èã®äœ¿çšã«ãããåæ£æ¶²ã®å Žåã«ãããŠèŠæ±
ãããç²åºŠãç¶æããããšã«ããããããŠçé¢æŽ»
æ§å€ã®äœ¿çšã«ãããç¶æããããšãã§ããã埮ç
ç©ã®äœçšã¯ãçš®ã ã®æ现èå€ããã³æçèå€ãã
ãšãã°ããã©ãã³ãã¯ãããã¿ããŒã«ãããšããŒ
ã«ããœã«ãã³é žããã¡ããµã«ãªã©ã«ããé²ãããš
ãã§ãããå€ãã®å Žåã«ãããŠãç匵å€ãããšã
ã°ãç ç³ãŸãã¯å¡©åãããªãŠã ãå ããããšã奜
ãŸããã泚å°çµæç©ã®åžåã¯ãåžåãé ãããç©
質ãããšãã°ãã¢ãã¹ãã¢ãªã³é žã¢ã«ãããŠã ã
ãã³ãŒã©ãã³ãçµæç©ã«å«æãããããšã«ããã
延é·ããããšãã§ããã æ» èãã泚å°æº¶æ¶²ã¯ã掻æ§ååç©ãèŠæ±éã§é©
åœãªæº¶åªäžã«ãå¿ èŠã«å¿ããŠãåè¿°ã®ä»ã®æåãš
äžç·ã«ãå質混åãã次ãã§éã«ããæžèãã
ããšã«ãã€ãŠã調補ããããäžè¬ã«åæ£æ¶²ã¯ãåº
æ¬çãªåæ£åªè³ªãšåè¿°ã®ãã®ããã®å¿ èŠãªä»ã®æ
åãå«æããæ» èããã¯ã«äžã«çš®ã ã®æ» èãã掻
æ§æåãå質混åããããšã«ãã€ãŠèª¿è£œãããæ»
èãã泚å°æº¶æ¶²ã調æŽããããã®æ» èç²æ«ã®å Žå
ã«ãããŠã奜ãŸãã調補æ³ã¯ç空也ç¥ããã³åçµ
也ç¥ã®æè¡ã§ããããããã«ããåè¿°ã®ããã«æ»
èéãã溶液ãã掻æ§æåãšè¿œå ã®æææåãš
ãããªãç²æ«ãåŸãããã ããã«äœ¿çšããããã«ãã補è¬åŠçã«èš±å®¹ãã
ãæ äœãã¯ä»»æã®ãã€ãã¹ãŠã®æº¶åªãåæ£åªè³ªã
被èãæ现èå€ãæçèå€ãç匵å€ããã³åžåé
延å€ãªã©ãå å«ããããã®ãããªè£œè¬åŠçç©è³ªã®
åªè³ªããã³å€ã¯ãåœåéã§ããç¥ãããŠãããåžž
çšã®åªè³ªãŸãã¯å€ã掻æ§æåãšäžé©æ§ã§ããå Žå
ãé€ããæ²»ççµæç©äžã®ãããã®äœ¿çšãèããã
ããè£å©æŽ»æ§æåãçµæç©ã«æ··å ¥ããããšãã§ã
ãã æäžã容æã§ãããã€åäžã«æäžããããããª
æäžåäœã®åœ¢æ ã«ãéçµå£çµæç©ãé åããããš
ã¯ãããšã«æå©ã§ãããããã§äœ¿çšããæäžåäœ
圢æ ãšã¯ãåŠçœ®ãã¹ãåºä¹³åç©ã®æ£è ãžã®åäžæ
äžã«é©ããç©ççã«åé¢ããåäœãæå³ããïŒå
åäœã¯ææã®æ²»çå¹æãçæããããã«èšç®ãã
åãã€ãŠæ±ºå®ããéã®æŽ»æ§ç©è³ªãå¿ èŠãªè£œè¬åŠç
æ äœãšäžç·ã«å«æãããæ¬çºæã®æ°èŠãªæäžåäœ
圢æ ã®èŠæ Œã¯ã(a) 掻æ§ç©è³ªã®åæã®ç¹æ§ããã³
åŸãããšããç¹å®ã®æ²»çå¹æãããã³(b) 身äœã®
å¥åº·ãããã«è©³ããé瀺ããããã«æãããç æ°
ã®ç¶æ ãæãããçããŠããæ£è ã«ãããç æ°ã®
åŠçœ®ã®ããã«ããã®ãããªæŽ»æ§ç©è³ªãé åæè¡ã«
åºæã®å¶éã«åŸãå€åããã€ãããã«çŽæ¥å·Šå³ã
ããã 䞻掻æ§æåã¯ã奜éœåãªãã€å¹æçãªæäžã®ã
ããæå¹éã§ãåè¿°ã®ãããªé©åœãªè£œè¬åŠçã«èš±
容ãããæ äœãšæäžåäœåœ¢æ ã«é åããããæäž
åäœåœ¢æ ã¯ãããšãã°ã䞻掻æ§æåãçŽ0.1ãçŽ
400mgã奜ãŸããçŽïŒãçŽ30mgã®éã§å«æã§ããã
æ¯çã§è¡šãããšã掻æ§ååç©ã¯äžè¬ã«çŽ0.1ãçŽ
400mgïŒmlæ äœã§ååšãããè£å©æŽ»æ§æåãå«æ
ããçµæç©ã®å Žåã«ãããŠãæäžéã¯åèšæåã®
éåžžã®æäžéããã³æäžéãåç §ããŠæ±ºå®ãã
ãã çã®åŸéããã³ç·©åã¯ãããšãã°ãè ¹è å æäž
ãçšããŠãéæããããåäžã®éèå æäžãŸãã¯
å埩ããæ¯æ¥ã®æäžãè¡ãããšãã§ãããçŽïŒã
10æ¥ãŸã§ã®æ¯æ¥ã®æäžã¯ãã°ãã°ååã§ããããŸ
ãæ¯æ¥ïŒåã®æäžãŸãã¯ïŒåã®æäžãïŒæ¥çœ®ããŸ
ãã¯ããããå°ãªãé »åºŠã®æ¥ã«åé ããããšãã§
ãããæäžé€çæ³ããæãããªããã«ãæäžãã
䞻掻æ§æåã¯ãçãå容ãã宿䞻ã«å¯ŸããŠçŽ°èæ¯
æ§ã®é床ã®æªãå¯äœçšã®ååšã§ãçœè¡ç ãªã©ã®åŸ
éããã³ç·©åãå©ããã®ã«ååãªéã§ãããçã®
ç æ°ã¯çœè¡ç ã®ãããªè¡æ¶²ã®æªæ§è «çãªãã³ã«è²
æ¯çãèºçããã³ä¹³çã®ãããªä»ã®å å®æ§ããã³
éå å®æ§ã®æªæ§è «çãæå³ãããåŸéããã³ç·©å
ã¯ãåŠçœ®äžååšã®ç æ°ã®é²è¡ã«æ¯ã¹ãŠãè «çã®æ
é·ãŸãã¯ä»ç æ°ã®çºçŸãé»æ¢ãŸãã¯é 延ããããš
ãæå³ããã æ¬çºæãã次ã®ç¹å®ã®å®æœäŸã«é¢é£ããŠããã
ã«è©³ãã説æããã å®æœäŸ ïŒ ïŒïŒ1â²âãã€ãããã¹ïŒãšãã¬ã³ã€ããâãšã
ã¬ã³ã€ããïŒããã¹ãïŒïŒïŒâãžããããã·â
ïŒâããïŒâïŒïŒâããããã·ãšãã«ã¢ããïŒãš
ãã«ãã¢ãããã¢ã³ã¹ã©ããã³ãããã©ããã
ã¯ãã©ã€ã ïŒâã¡ããã·ãšã¿ããŒã«ïŒ280mlïŒããããŸã
ãªãã15åéã®çªçŽ ã®æ³¡ç«ãŠéå ¥ã«ããè±æ°ãã
次ãã§10.97ïœïŒ0.04ã¢ã«ïŒã®ãã€ã³ïŒïŒïŒïŒïŒïŒ
ïŒâããã©ããããã·ã¢ã³ã¹ã©ããã³ãå ããã
ããŠçªçŽ é°å²æ°äžã§ãããŸãã25âã§ïŒæéç¶ã
ãããã®æ··åç©ã氷济äžã§ïŒåéå·åŽãã次ãã§
3.786ïœïŒ0.02ã¢ã«ïŒã®åèžçããããã©ãšãã¬
ã³ãã³ã¿ãã³ïŒå転ãã©ã·å¡äžã§åçããïŒæ²žç¹
185âïŒïŒmmHgïŒããããŸããæ··åç©ã«çªçŽ é°å²
æ°äžã§ç®äžæ³šå°åšããïŒåéã«ããã滎ã å ã
ãããã®æ··åç©ãïŒæéãããŸãããã®é枩床ã¯
ïŒâãã22âã«å¢å ãã次ãã§å ç±ããªã油济ã«
å ¥ãããçªçŽ é°å²æ°äžã§ç¶ãããã®é济ã®æž©åºŠã
50âã«åŸã ã«äžæãã次ãã§æ··åç©ã50âã§ãã
ã«ïŒæéå ç±ãããïŒâïŒïŒâã¢ãããšãã«ã¢ã
ãïŒãšã¿ããŒã«ïŒ4.166ïœã0.04ã¢ã«ïŒããæ··å
ç©ã«ç®äžæ³šå°åšã§å ãããçªçŽ é°å²æ°äžã§ãããŸ
ãããã³å ç±ã15æéç¶ããããã®åå¿æ··åç©ã
å·åŽããããã€ã³åœ¢ã®çæç©ã®çããæžæ¿æ¶²ã
10.01ïœïŒ0.0408ã¢ã«ïŒã®ã¯ãã©ãã«ãæ·»å ãã
ãã®æ··åç©ã氷济äžã§å·åŽããªãã25.0mlã®8N
ãšã¿ããŒã«æ§å¡©åæ°ŽçŽ ã滎ã å ãã次ãã§å·åŽã
ãããšãªã15æéãããŸããããšã«ããé žåã
ããçããæ··åç©ãé å¿åé¢ããåºäœãïŒåãã
ã©ããããã©ã³ã§æŽããéããŠ20.19ïœã®æé
è²åºäœãåŸããåºäœã15æé宀枩ã«ãããŠ360ml
ã®æ°Žãšäžç·ã«ãããŸããããã®æº¶æ¶²ã30åé17ïŒ
000Gã§é å¿åé¢ãã次ãã§ãã«ã³ãããéã
ããçæç©ãã5.9mlã®12.2Nå¡©é žã®æ·»å ã«ããé ž
æ§ã«ããããšã«ããã液ããåæ²æ®¿ããããã®
æ··åç©ã18ïŒ000Gã§25åéé å¿åé¢ãããçã
ãåºäœãé«éãããŸãæ©ã§åæ£ã«ããåå350ml
ã®0.2Nå¡©é žã§ïŒåæŽæµãã次ãã§17000Gã§é å¿
åé¢ãã次ãã§ãšã¿ããŒã«ã§ïŒåæŽæµããéã«
ãã8.56ïœã®ãã®å®æœäŸã®çæç©ãæéè²åºäœãš
ããŠåŸãïŒU.V.ïŒH2Oã10.31mcg.ïŒmlïŒ240nm
ïŒÎµ60ïŒ200ïŒã275ïŒ20ïŒ400ïŒã564shïŒ17ïŒ400ïŒã
609ïŒ28ïŒ100ïŒã660shïŒ20ïŒ400ïŒããããâã¹ããŒ
ãžïŒhotâstageïŒé¡åŸ®é¡ãçšããŠèŠ³å¯ããè©Šæã¯
350âãŸã§æº¶èããªããã·ãªã«ã²ã«ãçšããèå±€
ã¯ãããã°ã©ãã€ãŒãè¡ãã0.2ã¢ã«ã®æ°Žæ§ã¯ãš
ã³é žãã¢ã»ããããªã«ããã³é ¢é žã60ïŒ40ïŒïŒã®
äœç©æ¯ã§çšãããšãRf0.0ã«çæç©ã瀺ãããã
ãŠäžã®åæããã®èããããå¯çç©ã§ããä»ã®æ
è «çæ§ååç©ãïŒïŒïŒâãžããããã·âïŒïŒïŒâ
ãã¹âãïŒâãïŒâïŒïŒâããããã·ãšãã«ïŒã¢ã
ãããšãã«ãã¢ããâïŒïŒ10âã¢ã³ã¹ã©ã»ã³ãžãª
ã³ãžãããã¯ããªãïŒRf0.4ïŒã瀺ããªãã€ãã
åŸè ã®ååç©ïŒMurdockïŒet alïŒïŒlocïŒcitïŒïŒ
ã¯ãæ¬çºæã®çæç©ãšç°ãªããçäœç©ã®12Nå¡©é ž
ãå ããŠããã氎溶液ããæ²æ®¿ããªãã å®æœäŸ ïŒ ãã€ã³ïŒïŒ1â²âãã€ãããã¹ïŒãšãã¬ã³ã€ãã
âãšãã¬ã³ã€ããïŒããã¹ãïŒïŒïŒâãžããã
ãã·âïŒâããïŒâïŒïŒâããããã·ãšãã«ã¢ã
ãïŒãšãã«ãã¢ãããã¢ã³ã¹ã©ããã³ å®æœäŸïŒã®æé ãå埩ãããããã ããã€ã³å
ã®çæç©ãé žæ§ã«ãããããã¯ã¯ãã©ãã«ã§é žå
ããªãã§ãé å¿åé¢ã«ããéãããšã¿ããŒã«ã§æŽ
æµããŠãæšé¡ååç©ãèµ€ãã€è²åºäœãšããŠåŸãã å®æœäŸïŒã®æšé¡ååç©ã®ãã€ã³äœã«çžåœããã
ã®çæç©ã¯ã350âãŸã§æº¶èãããå®æœäŸïŒã®å
åç©ã®U.Vã¹ãã¯ãã«ã«é ·äŒŒããU.Vã¹ãã¯ãã«
ãäžããã å®æœäŸ ïŒ ïŒïŒ1â²âããšãã¬ã³ãã¹ïŒã€ãããšãã¬ã³ã€ã
ãïŒããã¹ãïŒïŒïŒâãžããããã·âïŒâããïŒ
âïŒïŒâããããã·ãšãã«ã¢ããïŒãšãã«ãã¢
ãããã¢ã³ã¹ã©ããã³ããã©ãããã¯ãã©ã€ã å®æœäŸïŒã®æé ãå埩ããããããã©ãšãã¬ã³
ãã³ã¿ãã³ã®ä»£ããã«2.925ïœã®ããªãšãã¬ã³ã
ãã©ãã³ã䜿çšãããšã1.86ïœã®ææçæç©ãé
é»è²åºäœãšããŠåŸããããm.p.ïŒ350âã å®æœäŸ ïŒ ïŒïŒ1â²âããªã¯ã¿ã¡ãã¬ã³ãžã€ããïŒãã¹ãïŒïŒ
ïŒâãžããããã·âïŒâããïŒâïŒïŒâãããã
ã·ãšãã«ã¢ããïŒãšãã«ãã¢ãããã¢ã³ã¹ã©ã
ãã³ããžãããã¯ãã©ã€ã å®æœäŸïŒã®çž®åããã³é žåæé ãå€æŽããŠãã
ãã©ãšãã¬ã³ãã³ã¿ãã³ã®ä»£ããã«ã10mlã®ïŒâ
ã¡ããã·ãšã¿ããŒã«äžã®2.88ïœã®ïŒïŒïŒâãžã¢ã
ããªã¯ã¿ã³ã®æº¶æ¶²ãçšãããé žåãããæ··åç©ã
é å¿åé¢ããæ²éããåºäœãããã©ããããã©ã³
ã§éã«ããïŒåæŽæµãããããã400mlã®0.6N
å¡©é žäžã«æžæ¿ãã18ïŒ000ïœã§é å¿åé¢ãããã
ã®ãã¬ããã1Nå¡©é žäžã«ïŒååæ£ãã17ïŒ000G
ã§é å¿åé¢ã«ããæŽæµãã次ãã§é å¿åé¢ã«ãã
ãšã¿ããŒã«ã§æŽæµããæåŸã«é å¿åé¢ã«ããã¢ã»
ãã³ã§æŽæµãããšã11.08ïœã®ãã®å®æœäŸã®çæ
ç©ãéé»è²åºäœãšããŠåŸããããm.p.180â185
âã å®æœäŸ ïŒ ïŒïŒ1â²âãã€ãããã¹ïŒãšãã¬ã³ã€ããïŒããã¹
ãïŒïŒïŒâãžããããã·âïŒâããïŒâïŒïŒâãã
ããã·ãšãã«ã¢ããïŒãšãã«ãã¢ãããã¢ã³ã¹
ã©ããã³ãããªãããã¯ãã©ã€ã ããã©ãšãã¬ã³ãã³ã¿ãã³ã®ä»£ããã«2.06ïœã®
ãžãšãã¬ã³ããªã¢ãã³ãçšããå®æœäŸïŒã®çž®åã
ãã³é žåãè¡ããšã17.15ïœã®æšé¡ååç©ãéé»
è²åºäœãšããŠåŸããããããã¯215â以äžã§çŒçµ
ãããããã¯æ¬è³ªçã«æ°Žäžæº¶æ§ã§ããã å®æœäŸ ïŒ ïŒïŒ1â²âãããªã¡ãã¬ã³ãã¹ïŒã€ãããšãã¬ã³
ã€ããïŒããã¹ãïŒïŒïŒâãžããããã·âïŒâ
ããïŒâïŒïŒâããããã·ãšãã«ã¢ããïŒãšãã«ã
ã¢ãããã¢ã³ã¹ã©ããã³ãããã©ãããã¯ãã©
ã€ã å®æœäŸïŒã®æé ãå埩ããŠãããã©ãšãã¬ã³ã
ã³ã¿ãã³ã®ä»£ããã«3.20ïœã®ïŒ®ïŒNâ²âãã¹ïŒïŒâ
ã¢ãããšãã«ïŒâïŒïŒïŒâãããã³ãžã¢ãã³ïŒå
çãããã®ïŒæ²žç¹190âïŒ50mmïœïŒã䜿çšããã
ãã®çæç©ã¯1.93ïœã®éé»è²åºäœã§ãããm.p.ïŒ
350âã§ããã å®æœäŸ ïŒ ïŒïŒ1â²âãïŒâãããã¬ã³ãã¹ïŒã€ãããšãã¬
ã³ã€ããïŒããã¹ãïŒïŒïŒâããããã·âïŒâ
ããïŒâïŒïŒâããããã·ãšãã«ã¢ããïŒãšãã«ã
ã¢ãããã¢ã³ã¹ã©ããã³ãããã©ãããã¯ãã©
ã€ã å®æœäŸïŒã®çž®åããã³é žåã®æé ãå€æŽããŠã
ããã©ãšãã¬ã³ãã³ã¿ãã³ã®ä»£ããã«3.44ïœã®
ïŒNâ²âãã¹ïŒïŒâã¢ãããšãã«ïŒâïŒâããã³
âïŒïŒïŒâãžã¢ãã³ïŒåçãããã®ïŒæ²žç¹169
âïŒïŒmmïœïŒã䜿çšãããç²è£œã®é žåçæç©ã¯
11.81ïœã®éé»è²åºäœã§ããã360mlã®æ°Žäžã®ãã®
åºäœã15åéãããŸããããã®æº¶æ¶²ã18ïŒ000G
ã§é å¿åé¢ããéããã液ã5.9mlã®12.3Nå¡©
é žã§0.2Nã«é žæ§ã«ããçãã綿ç¶ã®åºãŸãã®æž
æ¿æ¶²ã18ïŒ000Gã§é å¿åé¢ãããäžæŸã¿æ¶²ãã
ã«ã³ãããéããã液ã5.9mlã®12.3Nå¡©é žã§
0.4Nã«é žæ§ã«ããé å¿åé¢ãããäžæŸæ¶²ããã«
ã³ãããæ®çåºäœããšã¿ããŒã«ã§ïŒåæŽæµããŠã
161ïœã®ãã®å®æœäŸã®çæç©ãæéè²åºäœãšããŠ
åŸãm.p.ïŒ350âã å®æœäŸ ïŒ ïŒïŒ1â²âãããã©ã¡ãã¬ã³ãã¹ïŒã€ãããšãã¬
ã³ã€ããïŒããã¹ãïŒïŒïŒâãžããããã·âïŒ
âããïŒâïŒïŒâããããã·ãšãã«ã¢ããïŒãšã
ã«ãã¢ãããã¢ã³ã¹ã©ããã³ãããã©ãããã¯
ãã©ã€ã 100mlã®ãšã¿ããŒã«äžã®12.00ïœã®åçããïŒ
Nâ²âãã¹ïŒïŒâã¢ãããšãã«ïŒâïŒâããã³â
ïŒïŒïŒâãžã¢ãã³ïŒæ²žç¹169âïŒïŒmmïœïŒã®æº¶
液ããããŒã«ïŒParrïŒåæ°ŽçŽ ååšå ã§60psiïŒ4.2
KgïŒcm2ïŒã®åææ°ŽçŽ å§ã«ãããŠ2.00ïœã®ã©ããŒã
ãã±ã«è§Šåªã®ååšã§19âã§ïŒæéæ¯ãšãããã溶
液ãéãã次ãã§å転ãã©ã·å¡äžã§åçãã
ãšã9.19ïœã®ïŒ®ïŒNâ²âãã¹ïŒïŒâã¢ãããšãã«ïŒ
âïŒïŒïŒâãã¿ã³ãžã¢ãã³ãåŸãããã沞ç¹161
â162âïŒïŒmmïœã ããã©ãšãã¬ã³ãã³ã¿ãã³ã®ä»£ããã«3.49ïœã®
ãã®ããªã¢ãã³ãçšãããšã2.91ïœã®æšé¡ååç©
ãæéè²åºäœãšããŠåŸãããããã¯205âããã
ããã«çŒçµãããã350âãŸã§æº¶èããªãã å®æœäŸ ïŒ ïŒïŒ1â²âãããã©ã¡ãã¬ã³ãã¹ïŒã€ããããªã¡
ãã¬ã³ã€ããïŒããã¹ãïŒïŒïŒâãžããããã·
âïŒâããïŒâïŒïŒâããããã·ãšãã«ã¢ããïŒ
ãšãã«ãã¢ãããã¢ã³ã¹ã©ããã³ãããã©ãã
ãã¯ããªã å®æœäŸïŒã®æé ã¯ïŒåã®ïŒèŠæš¡ã§å埩ãããã
ã©ãšãã¬ã³ãã³ã¿ãã³ã®ä»£ããã«2.02ïœã®ã¹ãã«
ãã³ã䜿çšãããææçæç©ã¯1.87ïœã®æéè²åº
äœãšããŠåŸããããèç¹çŽ190â199âã å®æœäŸ 10 ïŒïŒ1â²âããšãã¬ã³ãã¹ïŒã€ãããšãã¬ã³ã€ã
ãïŒããã¹ãïŒïŒïŒâãžããããã·âïŒâãïŒïŒ
âã¡ãã¬ã³ã¢ãããšãã«ïŒã¢ãããã¢ã³ã¹ã©ã
ãã³ãããã©ãããã¯ãã©ã€ã åçããããªãšãã¬ã³ããã©ãã³2.92ïœïŒæ²žç¹
140âïŒïŒmmïœãn20 D1.4981ïŒããã³2.96ïœã®ïŒ®
âã¡ãã¬ã³ãžã¢ãã³ããå®æœäŸïŒã®æé ã«ãã
ãŠãããããããã©ãšãã¬ã³ãã³ã¿ãã³ããã³ïŒ
âïŒïŒâã¢ãããšãã«ã¢ããïŒãšã¿ããŒã«ã®ä»£ã
ãã«äœ¿çšãããæ°Žæ§æœåºæ¶²ããã®çæç©ã®å¹æç
ãªåæ²æ®¿ã¯ã11.8mlã®12.3Nå¡©é žãçšãã0.4Nãž
ã®é žçåããã³åŒãç¶ã17ïŒ000Gã«ãããé å¿
åé¢ã«ããéæããããåŸãããåºäœã¯é å¿åé¢
ã«ããåå150mlã®0.4Nå¡©é žã§ïŒåãéã«ãã
ãšã¿ããŒã«ã§ïŒåããããŠéã«ããã¢ã»ãã³ã§
ïŒåãããããæŽæµãããšã6.50ïœã®ææçæç©
ãæéè²åºäœãšããŠåŸããããm.p.ïŒ350âãïŒ
U.V.ïŒH2Oã9.31mcg.ïŒmlïŒïŒÎ»max235nmïŒÎµ56ïŒ
300ïŒ274shïŒ19ïŒ800ïŒã608ïŒ23ïŒ600ïŒã658shïŒ15ïŒ
100ïŒã å®æœäŸ 11 ïŒïŒ1â²âããšãã¬ã³ãã¹ïŒã€ãããšãã¬ã³ã€ã
ãïŒããã¹ãïŒâããïŒâïŒïŒâããããã·ãšãã«
ã¢ããïŒãšãã«ãã¢ãããã¢ã³ã¹ã©ããã³ãã
ãã©ãããã¯ããªã åçããããªãšãã¬ã³ããã©ãã³2.92ïœïŒæ²žç¹
140âïŒïŒmmïœãn20âD1.4981ïŒããã³9.69ïœã®
ãã€ã³ããã¶ãªã³ããå®æœäŸïŒã®æé ã«ãããŠã
ããããããã©ãšãã¬ã³ãã³ã¿ãã³ããã³ãã€ã³
ïŒïŒïŒïŒïŒïŒïŒâããã©ããããã·ã¢ã³ã¹ã©ãã
ã³ã®ä»£ããã«äœ¿çšãããç²è£œã®é žåããçæç©ã®
æ°Žæ§æœåºæ¶²ãã11.8mlã®12.3Nå¡©é žã§0.4Nã®é žç
åã«ãã次ãã§17ïŒ000Gã§é å¿åé¢ãããäžæŸ
ã¿æ¶²ããã«ã³ããããããŠéããã液ã11.8
mlã®12.3Nå¡©é žã§0.8Nã«é žæ§ã«ããäžã®ããã«é
å¿åé¢ãããäžæŸã¿æº¶æ¶²ããã«ã³ãããæ®çç©ã
é å¿åé¢ã«ããåå50.0mlã®0.8Nå¡©é žã§æŽæµãã
次ãã§ãšã¿ããŒã«ã§éã«ããïŒåæŽæµãããšã
2.61ïœã®ãã®å®æœäŸã®çæç©ã玫é»è²åºäœãšããŠ
åŸããããm.p.175â180âïŒU.V.ïŒH2Oã
12.36mcg.ïŒmlïŒïŒÎ»max253nmïŒÎµ56ïŒ300ïŒ327
ïŒïŒïŒ000ïŒã552shïŒ15ïŒ400ïŒã582ïŒ18ïŒ400ïŒã
626shïŒ11.900ïŒ å®æœäŸ 12 ãè¡šã ïŒïŒ1â²âãã€ãããã¹ïŒãšãã¬ã³ã€ããïŒããã¹
ãïŒïŒïŒâãžããããã·âïŒâããïŒâïŒïŒâããã
ãã·ãšãã«ã¢ããïŒãšãã«ãã¢ãããã¢ã³ã¹ã©ã
ãã³ãããã©ãããã¯ãã©ã€ããã©ã¯ããŒã¹ãã
ã³ã³ãŒã³ã¹ã¿ãŒãïŒæ··åç©çšïŒãäžç·ã«é åã
ããã³ãŒã³ã¹ã¿ãŒãïŒããŒã¹ãçšïŒã600mlã®æ°Ž
äžã«æžæ¿ãããããŸããªããå ç±ããŠããŒã¹ãã
圢æããã次ãã§ãã®ããŒã¹ãã䜿çšããŠæ··åã
ãç²æ«ãé ç²ãããè¿œå ã®æ°Žãå¿ èŠã«å¿ãæ··åã
ãããã®æ¹¿ã€ãç²äœãNo.ïŒã®ææã¡ãµããã«é
ãã120ãïŒ48.9âïŒã§ä¹Ÿç¥ããã次ãã§ä¹Ÿç¥ã
ãç²äœãNo.16ãµããã«éãããã®æ··åç©ãïŒïŒ ã®
ã¹ãã¢ãªã³é žãã°ãã·ãŠã ã§æœ€æ»ãããããŠé©åœ
ãªé å€åœ¢ææ©ã§é å€ã«ãã¬ã¹ããã å®æœäŸ 13 éçµå£æº¶æ¶²ã®èª¿è£œ 泚å°çšã®700mlã®ãããã¬ã³ã°ãªã³ãŒã«ããã³
200mlã®æ°Žã®æº¶æ¶²äžã«ã20.0ïœã®ïŒïŒ1â²âãã€ãã
ãã¹ïŒãšãã¬ã³ã€ããâãšãã¬ã³ã€ããïŒããã¹
ãïŒïŒïŒâãžããããã·âïŒâããïŒâïŒïŒâããã
ãã·ãšãã«ã¢ããïŒãšãã«ãã¢ãããã¢ã³ã¹ã©ã
ãã³ãããã©ãããã¯ãã©ã€ãããããŸããªãã
æžæ¿ãããæžæ¿ãå®çµåãPHãå¡©é žã§5.5ã«èª¿æŽ
ããäœç©ã泚å°çšã®æ°Žã§1000mlã«ããã調補ç©ã
æ» èãã5.0mlã®ã¢ã³ãã«ã«å å¡«ããåã¢ã³ãã«
ã¯2.0mlïŒ40mgã®è¬ç©ãè¡šããïŒãå«æããçªçŽ
é°å²æ°äžã§å¯éããã å®æœäŸ 14 ïŒïŒ1â²âïŒãšãã¬ã³ãžã€ããïŒãã¹ãïŒâïŒïŒâ
ã¢ãããšãã«ïŒã¢ãããïŒïŒïŒâãžããããã·
ã¢ã³ã¹ã©ããã³ãžãããã¯ããªã 160mlã®ïŒ®ïŒïŒ®ïŒNâ²ïŒNâ²âããã©ã¡ãã«ãšãã¬
ã³ãžã¢ãã³äžã®14.44ïœã®ãšãã¬ã³ãžã¢ãã³ã®æº¶
液ãããããŸããªããçªçŽ ã泡ç«ãŠãŠ15åééå ¥
ããŠè±æ°ããã41.94ïœã®ãã€ã³ïŒïŒïŒïŒïŒïŒïŒ
âããã©ããããã·ã¢ã³ã¹ã©ããã³ãå ããåŸã
ãã®æ··åç©ãçªçŽ é°å²æ°äžã§25âã«ãããŠïŒæé
ãããŸãã次ãã§48â50âã®æ²¹æµŽã§å ç±ããªãã
ããã«ïŒæéãããŸããããã®æ··åç©ãå·åŽãã
åºäœãéã«ããéãããšã¿ããŒã«ã§æŽæµããŠã
28.25ïœã®ç·é»è²åºäœãåŸãããã®ããã€ã³ãä»
å ç©ããå®æœäŸïŒã«ãããããã«ã14.4mlã®8N
ãšã¿ããŒã«æ§å¡©åæ°ŽçŽ ãå«æãã565mlã®ïŒâã¡
ããã·ãšã¿ããŒã«ã§19.77ïœã®ã¯ãã©ãã«ã«ãã
é žåãããåºäœãéã«ããéããããã©ããã
ãã©ã³ã§æŽæµãããšã29.66ïœã®éé»è²åºäœãåŸ
ãããããã®åºäœã¯æ°Žæº¶æ§å¯çç©ã®ïŒïŒïŒâãã¹
ïŒïŒâã¢ãããšãã«ã¢ããïŒâïŒïŒïŒâãžãããã
ã·ã¢ã³ã¹ã©ããã³äºå¡©é žå¡©ãå«æããããã800
mlã®æ°Žãšãšãã«14æéãããŸããé å¿åé¢ãã次
ãã§åºäœãé å¿åé¢ã«ããæŽæµããããšã«ãã€
ãŠãé€å»ãããäžæŽ»æ§ã®éé»è²åºäœïŒ6.8ïœïŒã¯
æšé¡ååç©ã§ãããããã¯350âãŸã§æº¶èããªãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžèšåŒã®ååç©ããã³ãããã®è£œè¬åŠçã«èš±
容ãããé žä»å å¡©ïŒ åŒäžã âã¯ãâCH2âCH2âãŸãã¯âCHïŒCHâ
ã§ããïŒ ïŒ±ã¯ãâCH2CH2NHâCH2CH2OHãâ
CH2CH2NHâCH2CH2NH2ãŸãã¯â
CH2CH2NHâCH2CH2NHCH3ã§ããïŒãã
㊠ã¯ãâïŒCH2ïŒïœâãããã§ïœã¯ïŒãïŒã®æŽæ°
ã§ãããâCH2CH2NHâCH2CHïŒCHCH2NH
âCH2CH2âã âïŒCH2ïŒ3NHâïŒCH2ïŒ4NHâïŒCH2ïŒ3âãâ
CH2CH2âïŒNHCH2CH2ïŒïœâãããã«ïœã¯
ïŒãïŒã®æŽæ°ã§ããããŸãã¯âCH2CH2NHâ
ïŒCH2ïŒïœâNHCH2CH2âãããã« ïœã¯ïŒãïŒã®æŽæ°ã§ããã ïŒ ïŒïŒ1â²âãã€ãããã¹ïŒãšãã¬ã³ã€ããâãš
ãã¬ã³ã€ããïŒããã¹ãïŒïŒïŒâãžããããã·â
ïŒâããïŒâïŒïŒâããããã·ãšãã«ã¢ããïŒãšã
ã«ãã¢ãããã¢ã³ã¹ã©ããã³ãããã©ãããã¯ã
ã©ã€ãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®åå
ç©ã ïŒ ïŒïŒ1â²âãã€ãããã¹ïŒã€ãããšãã¬ã³ã€ã
ãïŒããã¹ãïŒïŒïŒâãžããããã·âïŒâãïŒïŒâ
ïŒïŒâããããã·ãšãã«ã¢ããïŒãšãã«ãã¢ããã
ã¢ã³ã¹ã©ããã³ãããã©ãããã¯ãã©ã€ãã§ãã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ ïŒïŒ1â²âïŒãªã¯ã¿ã¡ãã¬ã³ãžã€ããïŒãã¹
ãïŒïŒïŒâãžããããã·âïŒâããïŒâïŒïŒâããã
ãã·ãšãã«ã¢ããïŒãšãã«ãã¢ãããã¢ã³ã¹ã©
ãããžãããã¯ãã©ã€ãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé èšèŒã®ååç©ã ïŒ ïŒïŒ1â²âãã€ãããã¹ïŒãšãã¬ã³ã€ããïŒãã
ã¹ãïŒïŒïŒâãžããããã·âïŒâããïŒâïŒïŒâã
ãããã·ãšãã«ã¢ããïŒãšãã«ãã¢ãããã¢ã³ã¹
ã©ããã³ãããªãããã¯ãã©ã€ãã§ããç¹èš±è«æ±
ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ ïŒïŒ1â²âãããªã¡ãã¬ã³ãã¹ïŒã€ãããšãã¬
ã³ã€ããïŒããã¹ãïŒïŒïŒâãžããããã·âïŒâ
ããïŒâïŒïŒâããããã·ãšãã«ã¢ããïŒãšãã«ã
ã¢ãããã¢ã³ã¹ã©ãããããã©ãããã¯ãã©ã€ã
ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ ïŒïŒ1â²âãïŒâãããã¬ã³ãã¹ïŒã€ãããšã
ã¬ã³ã€ããïŒããã¹ãïŒïŒïŒâããããã·âïŒâ
ããïŒâïŒïŒâããããã·ãšãã«ã¢ããïŒãšãã«ã
ã¢ãããã¢ã³ã¹ã©ããã³ãããã©ãããã¯ãã©ã€
ãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ ïŒïŒ1â²âãããã©ã¡ãã¬ã³ãã¹ïŒã€ãããšã
ã¬ã³ã€ããïŒãã¹ãïŒïŒïŒâãžããããã·âïŒâ
ããïŒâïŒïŒâããããã·ãšãã«ã¢ããïŒãšãã«ã
ã¢ãããã¢ã³ã¹ã©ããã³ãããã©ãããã¯ãã©ã€
ãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã ïŒ åŒ åŒäžã âã¯ãâCH2âCH2âãŸãã¯âCHïŒCHâ
ã§ããïŒ ïŒ±ã¯ãâCH2CH2NHâCH2CH2OHãâ
CH2CH2NHâCH2CH2NH2ãŸãã¯â
CH2CH2NHâCH2CH2NHCH3ã§ããïŒãã
㊠ã¯ãâïŒCH2ïŒïœâãããã§ïœã¯ïŒãïŒã®æŽæ°
ã§ãããâCH2CH2NHâCH2CHïŒCHCH2NH
âCH2CH2âã âïŒCH2ïŒ3NHâïŒCH2ïŒ4NHâïŒCH2ïŒ3âãâ
CH2CH2âïŒNHCH2CH2ïŒïœâãããã«ïœã¯
ïŒãïŒã®æŽæ°ã§ããããŸãã¯âCH2CH2NHâ
ïŒCH2ïŒïœâNHCH2CH2âãããã«ïœã¯ïŒã
ïŒã®æŽæ°ã§ããã ã®ååç©ãŸãã¯ãããã®è£œè¬åŠçã«èš±å®¹ãããé ž
ä»å å¡©ã補é ããã«ããããçŽïŒã¢ã«ã®åŒïŒ ã®ãã€ã³ããã¶ãªã³ãçŽïŒã¢ã«ã®åŒïŒ NH2ââNH2 åŒäžãã¯äžã«å®çŸ©ãããšããã§ããã ã®ã¢ã«ãã¬ã³ãžã¢ãã³ãšäžæŽ»æ§æº¶åªäžã«ãããŠçŽ
ïŒâã50âã®æž©åºŠã§çž®åããŠåŒïŒ åŒäžãã¯äžã«å®çŸ©ãããšããã§ããã ã®ïŒïŒ1â²âãã¹âãã€ã³äžéäœãçæããïŒæ¬¡ã
ã§ãããåŒïŒ H2Nâ åŒäžãã¯äžã«å®çŸ©ãããšããã§ããã ã®ã¢ãã³ãšäžæŽ»æ§æº¶åªäžã«ãããŠãäžæŽ»æ§é°å²æ°
äžã«ãçŽ40âãçŽ60âã®æž©åºŠã§çž®åããŠãã€ã³å¡©
åºãåŸïŒãããŠãéæã«ããã®ããã«ããŠåŸãã
ã€ã³å¡©åºãé žåããŠè³éŠæåã«è»¢åãããããšã
ç¹åŸŽãšããæ¹æ³ã ïŒïŒ ãã€ã³å¡©åºã®é žåãããã€ã³å¡©åºã«ã¯ãã©
ãã«ãæ·»å ãããã®æ··åç©ã氷济äžã§å·åŽããªã
ããããã«å¡©åæ°ŽçŽ ã®8Nãšã¿ããŒã«æº¶æ¶²ã滎äž
ããããšã«ããè¡ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èš
èŒã®æ¹æ³ã
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/164,615 US4278605A (en) | 1980-06-30 | 1980-06-30 | Heteroalkylenebisanthraquinones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5785345A JPS5785345A (en) | 1982-05-28 |
| JPH0243728B2 true JPH0243728B2 (ja) | 1990-10-01 |
Family
ID=22595305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56099783A Granted JPS5785345A (en) | 1980-06-30 | 1981-06-29 | Heteroalkylene bisanthraquinones and manufacture |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4278605A (ja) |
| EP (1) | EP0042940B1 (ja) |
| JP (1) | JPS5785345A (ja) |
| KR (1) | KR840001309B1 (ja) |
| CA (1) | CA1169057A (ja) |
| DE (1) | DE3163961D1 (ja) |
| NZ (1) | NZ197556A (ja) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0083683A1 (en) * | 1981-10-26 | 1983-07-20 | American Cyanamid Company | Method of preparing 1,4-bis(substituted-amino)-5,8-dihydroxyanthraquinones and pharmaceutical compositions containing them |
| ATE48942T1 (de) * | 1984-02-27 | 1990-01-15 | American Cyanamid Co | Verwendung von 1,4 bisubstituierten anthrachinonen zur herstellung von immunsuppressiva. |
| GB8923075D0 (en) * | 1989-10-13 | 1989-11-29 | Patterson Laurence H | Anti-cancer compounds |
| IT1237506B (it) * | 1989-10-27 | 1993-06-08 | Boehringer Biochemia Srl | Derivati amminici di 2,3-diaza-antracene-9,10-dioni come farmaci antitumorali |
| WO1995018091A1 (en) * | 1993-12-27 | 1995-07-06 | Ciba-Geigy Ag | Unsaturate amino compounds for use as anticancer and antiprotozoic agent |
| GB2318349A (en) * | 1996-10-15 | 1998-04-22 | Gyre Ltd | Biocidal composition for wet environment |
| US7851172B2 (en) * | 2006-07-25 | 2010-12-14 | University Of Kentucky Research Foundation | Biomarkers of mild cognitive impairment and alzheimer's disease |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1028717B (de) * | 1955-01-22 | 1958-04-24 | Basf Ag | Verfahren zur Herstellung von Anthrachinonfarbstoffen |
| FR1529724A (fr) * | 1967-04-21 | 1968-06-21 | Ugine Kuhlmann | Nouveaux colorants anthraquinoniques et intermédiaires pour leur préparation |
| US4027021A (en) * | 1974-08-23 | 1977-05-31 | The Upjohn Company | Interferon induction |
| DE2722507A1 (de) * | 1977-05-18 | 1978-11-23 | Allied Chem | Anthrachinonderivate |
| SE445996B (sv) * | 1977-08-15 | 1986-08-04 | American Cyanamid Co | Nya atrakinonderivat |
| US4197249A (en) * | 1977-08-15 | 1980-04-08 | American Cyanamid Company | 1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof |
-
1980
- 1980-06-30 US US06/164,615 patent/US4278605A/en not_active Expired - Lifetime
-
1981
- 1981-05-08 DE DE8181103505T patent/DE3163961D1/de not_active Expired
- 1981-05-08 CA CA000377135A patent/CA1169057A/en not_active Expired
- 1981-05-08 EP EP81103505A patent/EP0042940B1/en not_active Expired
- 1981-06-29 JP JP56099783A patent/JPS5785345A/ja active Granted
- 1981-06-29 NZ NZ197556A patent/NZ197556A/xx unknown
- 1981-06-29 KR KR1019810002337A patent/KR840001309B1/ko not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE3163961D1 (de) | 1984-07-12 |
| NZ197556A (en) | 1983-09-30 |
| CA1169057A (en) | 1984-06-12 |
| JPS5785345A (en) | 1982-05-28 |
| US4278605A (en) | 1981-07-14 |
| KR830006179A (ko) | 1983-09-20 |
| KR840001309B1 (ko) | 1984-09-11 |
| EP0042940B1 (en) | 1984-06-06 |
| EP0042940A1 (en) | 1982-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Atwell et al. | Potential antitumor agents. Part 43. Synthesis and biological activity of dibasic 9-aminoacridine-4-carboxamides, a new class of antitumor agent | |
| Israel et al. | Analogs of Spermine and Spermidine. I. Synthesis of Polymethylenepolyamines by Reduction of Cyanoethylated α, ι-Alkylenediamines1, 2 | |
| JPH0255438B2 (ja) | ||
| JPH04502166A (ja) | å¶çååç© | |
| FI70882C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara antrakinonderivat | |
| LU85634A1 (fr) | Nouveaux derives de la carboxymethoxy-7 furo-(3,4-c)-pyridine,leur preparation et compositions therapeutiques a base de ces composes | |
| JPH0243728B2 (ja) | ||
| JPS61171495A (ja) | çœéé¯äœé¡åã³ãã®è£œé æ¹æ³ | |
| US6187787B1 (en) | Bis(9-aminoacridine) DNA intercalating agents having antitumor activity | |
| US7846939B2 (en) | Salts and mixture of 9-oxoacridine-10-acetic acid with 1-alkylamino-1-desoxy-polyols, pharmaceutical compositions containing said agents and treatment methods | |
| US4540788A (en) | Schiff bases of [(aminoalkyl or substituted aminoalkyl)amino]-9,10-anthracenediones | |
| US4389399A (en) | Thiocarbamoyl heterocycle-anthraquinone derivatives | |
| EP0027877B1 (en) | 5,8-dihydroxy-1,4-bis(guanidinyl-amino)anthraquinones | |
| JPS6361937B2 (ja) | ||
| US4428882A (en) | 1-(Aminoalkylamino)-5,8-dihydroxy-4-substituted-anthraquinones | |
| JP4235111B2 (ja) | è¶ ååã«ã«ããã©ãã³èªå°äœããã®è£œé æ¹æ³ã掻æ§æåãšããŠãã®èªå°äœãå«æããè¬åŠççµæç©ããã³ãã®äœ¿çš | |
| US4526788A (en) | Polymeric[[(oxazolidinyl)alkyl]amino]anthraquinones | |
| JP2528370B2 (ja) | æè «çå€ | |
| US4956457A (en) | Disazo disulfonamides compounds | |
| MarkoviÄ et al. | Synthesis and antioxidant activity of novel vanillin-based ferrocenyl chalcones | |
| JPH01221364A (ja) | ïœïœé転åé µçŽ é»å®³å€ããã³æè «çå€ | |
| Markees et al. | Synthesis and antibacterial activity of some substituted 4-quinolone-3-carboxylic acids | |
| US4375469A (en) | Oxaza heterocycle-anthraquinones, pharmaceutical compositions thereof and method of use thereof | |
| EP0083683A1 (en) | Method of preparing 1,4-bis(substituted-amino)-5,8-dihydroxyanthraquinones and pharmaceutical compositions containing them | |
| EP0085760A2 (en) | Novel 1-4-bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof |